February 5, 2016
Citations Reviewed by GINA Science Committee
Global Strategy for Asthma Diagnosis and Management Updated 2003
1.
Long-term effects of budesonide or nedocromil in children with asthma. The
Childhood Asthma Management Program Research Group. N Engl J Med
2000;343(15):1054-63.
2.
Affrime MB, Kosoglou T, Thonoor CM, Flannery BE, Herron JM. Mometasone
furoate has minimal effects on the hypothalamic-pituitary- adrenal axis when delivered at
high doses. Chest 2000;118(6):1538-46.
3.
Affrime MB, Cuss F, Padhi D, et al. Bioavailability and metabolism of
mometasone furoate following administration by metered-dose and dry-powder inhalers
in healthy human volunteers. J Clin Pharmacol 2000;40(11):1227-36.
4.
Agertoft L, Pedersen S. Effect of long-term treatment with inhaled budesonide on
adult height in children with asthma. N Engl J Med 2000;343(15):1064-9.
5.
Aziz I, Wilson AM, Lipworth BJ. Effects of once-daily formoterol and budesonide
given alone or in combination on surrogate inflammatory markers in asthmatic adults.
Chest 2000;118(4):1049-58.
6.
Baker JC, Duncanson RC, Tunnicliffe WS, Ayres JG. Development of a
standardized methodology for double-blind, placebo- controlled food challenge in
patients with brittle asthma and perceived food intolerance. J Am Diet Assoc
2000;100(11):1361-7.
7.
Baraldi E, Scollo M, Zaramella C, Zanconato S, Zacchello F. A simple flow-driven
method for online measurement of exhaled NO starting at the age of 4 to 5 years. Am J
Respir Crit Care Med 2000;162(5):1828-32.
8.
Baxter-Jones AD, Helms PJ. Early introduction of inhaled steroids in wheezing
children presenting in primary care. A pilot study. EASE Study Group. Clin Exp Allergy
2000;30(11):1618-26.
9.
Bousquet J, D'Urzo A, Hebert J, et al. Comparison of the efficacy and safety of
mometasone furoate dry powder inhaler to budesonide Turbuhaler. Eur Respir J
2000;16(5):808-16.
10.
Brenner BE, Chavda KK, Camargo CA, Jr. Randomized trial of inhaled flunisolide
versus placebo among asthmatic patients discharged from the emergency department.
Ann Emerg Med 2000;36(5):417-26.
11.
Bryan SA, O'Connor BJ, Matti S, et al. Effects of recombinant human interleukin12 on eosinophils, airway hyper-responsiveness, and the late asthmatic response.
Lancet 2000;356(9248):2149-53.
12.
Caffarelli C, Sensi LG, Marcucci F, Cavagni G. Preseasonal local allergoid
immunotherapy to grass pollen in children: a double-blind, placebo-controlled,
randomized trial. Allergy 2000;55(12):1142-7.
13.
Cazzola M, Di Lorenzo G, Di Perna F, Calderaro F, Testi R, Centanni S. Additive
effects of salmeterol and fluticasone or theophylline in COPD. Chest 2000;118(6):157681.
14.
Chalut DS, Ducharme FM, Davis GM. The Preschool Respiratory Assessment
Measure (PRAM): a responsive index of acute asthma severity. J Pediatr
2000;137(6):762-8.
15.
Chu HW, Kraft M, Krause JE, Rex MD, Martin RJ. Substance P and its receptor
neurokinin 1 expression in asthmatic airways. J Allergy Clin Immunol 2000;106(4):71322.
16.
Ciarallo L, Brousseau D, Reinert S. Higher-dose intravenous magnesium therapy
for children with moderate to severe acute asthma. Arch Pediatr Adolesc Med
2000;154(10):979-83.
17.
Csonka P, Kaila M, Laippala P, Kuusela AL, Ashorn P. Wheezing in early life and
asthma at school age: predictors of symptom persistence. Pediatr Allergy Immunol
2000;11(4):225-9.
18.
Duh MS, Walker AM, Lindmark B, Laties AM. Association between intraocular
pressure and budesonide inhalation therapy in asthmatic patients. Ann Allergy Asthma
Immunol 2000;85(5):356-61.
19.
Emeryk A, Bartkowiak-Emeryk M, Czerwinska-Pawluk I, Postepski J. [Usefulness
of peak expiratory flow measurement for selection of dry powder inhalers in asthmatic
children]. Pol Merkuriusz Lek 2000;9(52):667-70.
20.
Fish JE, Karpel JP, Craig TJ, et al. Inhaled mometasone furoate reduces oral
prednisone requirements while improving respiratory function and health-related quality
of life in patients with severe persistent asthma. J Allergy Clin Immunol 2000;106(5):85260.
21.
Gallefoss F, Bakke PS. Patient satisfaction with healthcare in asthmatics and
patients with COPD before and after patient education. Respir Med 2000;94(11):105764.
22.
Gauvreau GM, Wood LJ, Sehmi R, et al. The effects of inhaled budesonide on
circulating eosinophil progenitors and their expression of cytokines after allergen
challenge in subjects with atopic asthma. Am J Respir Crit Care Med 2000;162(6):213944.
23.
Gauvreau GM, Ronnen GM, Watson RM, O'Byrne PM. Exercise-induced
bronchoconstriction does not cause eosinophilic airway inflammation or airway
hyperresponsiveness in subjects with asthma. Am J Respir Crit Care Med 2000;162(4 Pt
1):1302-7.
24.
Giannini D, Di Franco A, Cianchetti S, et al. Analysis of induced sputum before
and after withdrawal of treatment with inhaled corticosteroids in asthmatic patients. Clin
Exp Allergy 2000;30(12):1777-84.
25.
Goldberg J, Bohning W, Schmidt P, Freund E. Fenoterol hydrobromide delivered
via HFA-MDI or CFC-MDI in patients with asthma: a safety and efficacy comparison.
Respir Med 2000;94(10):948-53.
26.
Gotshall RW, Mickleborough TD, Cordain L. Dietary salt restriction improves
pulmonary function in exercise- induced asthma. Med Sci Sports Exerc
2000;32(11):1815-9.
27.
Grembiale RD, Camporota L, Naty S, Tranfa CM, Djukanovic R, Marsico SA.
Effects of specific immunotherapy in allergic rhinitic individuals with bronchial
hyperresponsiveness. Am J Respir Crit Care Med 2000;162(6):2048-52.
28.
Groeben H, Grosswendt T, Silvanus M, Beste M, Peters J. Lidocaine inhalation
for local anaesthesia and attenuation of bronchial hyper-reactivity with least airway
irritation. Effect of three different dose regimens. Eur J Anaesthesiol 2000;17(11):672-9.
29.
Hasegawa T, Ishihara K, Takakura S, et al. Duration of systemic corticosteroids
in the treatment of asthma exacerbation; a randomized study. Intern Med
2000;39(10):794-7.
30.
Heuck C, Heickendorff L, Wolthers OD. A randomised controlled trial of short
term growth and collagen turnover in asthmatics treated with inhaled formoterol and
budesonide. Arch Dis Child 2000;83(4):334-9.
31.
Huntley A, Ernst E. Herbal medicines for asthma: a systematic review. Thorax
2000;55(11):925-9.
32.
Inaba S, Nibu K, Takano H, et al. Potassium-adsorption filter for RBC
transfusion: a phase III clinical trial. Transfusion 2000;40(12):1469-74.
33.
Jang AS, Choi IS, Koh YI, et al. Effects of prednisolone on eosinophils, IL-5,
eosinophil cationic protein, EG2+ eosinophils, and nitric oxide metabolites in the sputum
of patients with exacerbated asthma. J Korean Med Sci 2000;15(5):521-8.
34.
Johansson A, Bende M, Millqvist E, Bake B. Nasobronchial relationship after cold
air provocation. Respir Med 2000;94(11):1119-22.
35.
Johnson KB, Blaisdell CJ, Walker A, Eggleston P. Effectiveness of a clinical
pathway for inpatient asthma management. Pediatrics 2000;106(5):1006-12.
36.
Jonasson G, Carlsen KH, Mowinckel P. Asthma drug adherence in a long term
clinical trial. Arch Dis Child 2000;83(4):330-3.
37.
Joos S, Schott C, Zou H, Daniel V, Martin E. Immunomodulatory effects of
acupuncture in the treatment of allergic asthma: a randomized controlled study. J Altern
Complement Med 2000;6(6):519-25.
38.
Khan LN, Kon OM, Macfarlane AJ, et al. Attenuation of the allergen-induced late
asthmatic reaction by cyclosporin A is associated with inhibition of bronchial eosinophils,
interleukin-5, granulocyte macrophage colony-stimulating factor, and eotaxin. Am J
Respir Crit Care Med 2000;162(4 Pt 1):1377-82.
39.
Kim KT, Ginchansky EJ, Friedman BF, et al. Fluticasone propionate versus
zafirlukast: effect in patients previously receiving inhaled corticosteroid therapy. Ann
Allergy Asthma Immunol 2000;85(5):398-406.
40.
Kim YK, Park HW, Park HS, et al. Sensitivity to citrus red mite and the
development of asthma. Ann Allergy Asthma Immunol 2000;85(6 Pt 1):483-8.
41.
Koskela T, Malmstrom K, Sairanen U, Peltola S, Keski-Karhu J, Silvasti M.
Efficacy of salbutamol via Easyhaler unaffected by low inspiratory flow. Respir Med
2000;94(12):1229-33.
42.
Krum H, Ninio D, MacDonald P. Baseline predictors of tolerability to carvedilol in
patients with chronic heart failure. Heart 2000;84(6):615-9.
43.
L'Her E, Monchi M, Joly B, Marichy J, Lejay M, Dhainaut JF. Helium-oxygen
breathing in the early emergency care of acute severe asthma: a randomized pilot study.
Eur J Emerg Med 2000;7(4):271-5.
44.
LaForce CF, Pearlman DS, Ruff ME, et al. Efficacy and safety of dry powder
fluticasone propionate in children with persistent asthma. Ann Allergy Asthma Immunol
2000;85(5):407-15.
45.
Leckie MJ, ten Brinke A, Khan J, et al. Effects of an interleukin-5 blocking
monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late
asthmatic response. Lancet 2000;356(9248):2144-8.
46.
Lim TK, Chin NK, Lee KH, Stebbings AM. Early discharge of patients
hospitalized with acute asthma: a controlled study. Respir Med 2000;94(12):1234-40.
47.
Lim S, Jatakanon A, Gordon D, Macdonald C, Chung KF, Barnes PJ.
Comparison of high dose inhaled steroids, low dose inhaled steroids plus low dose
theophylline, and low dose inhaled steroids alone in chronic asthma in general practice.
Thorax 2000;55(10):837-41.
48.
Manjra AI, Price J, Lenney W, Hughes S, Barnacle H. Efficacy of nebulized
fluticasone propionate compared with oral prednisolone in children with an acute
exacerbation of asthma. Respir Med 2000;94(12):1206-14.
49.
Marrie TJ, Lau CY, Wheeler SL, Wong CJ, Feagan BG. Predictors of symptom
resolution in patients with community-acquired pneumonia. Clin Infect Dis
2000;31(6):1362-7.
50.
Maslow AD, Regan MM, Israel E, et al. Inhaled albuterol, but not intravenous
lidocaine, protects against intubation-induced bronchoconstriction in asthma.
Anesthesiology 2000;93(5):1198-204.
51.
Mochizuki H, Shigeta M, Arakawa H, Kato M, Tokuyama K, Morikawa A.
Bronchial hyperresponsiveness before and after the diagnosis of bronchial asthma in
children. Pediatrics 2000;106(6):1442-6.
52.
Nagakura T, Matsuda S, Shichijyo K, Sugimoto H, Hata K. Dietary
supplementation with fish oil rich in omega-3 polyunsaturated fatty acids in children with
bronchial asthma. Eur Respir J 2000;16(5):861-5.
53.
Nelson HS, Busse WW, Kerwin E, et al. Fluticasone propionate/salmeterol
combination provides more effective asthma control than low-dose inhaled corticosteroid
plus montelukast. J Allergy Clin Immunol 2000;106(6):1088-95.
54.
Neuman I, Nahum H, Ben-Amotz A. Reduction of exercise-induced asthma
oxidative stress by lycopene, a natural antioxidant. Allergy 2000;55(12):1184-9.
55.
Nielsen LP, Dahl R. Therapeutic ratio of inhaled corticosteroids in adult asthma.
A dose- range comparison between fluticasone propionate and budesonide, measuring
their effect on bronchial hyperresponsiveness and adrenal cortex function. Am J Respir
Crit Care Med 2000;162(6):2053-7.
56.
Nielsen KG, Bisgaard H. The effect of inhaled budesonide on symptoms, lung
function, and cold air and methacholine responsiveness in 2- to 5-year-old asthmatic
children. Am J Respir Crit Care Med 2000;162(4 Pt 1):1500-6.
57.
Noseda A, De Bruyne I, De Maertelaer V, Yernault JC. Does an IV bolus of
methylprednisolone relieve dyspnea in asthma exacerbations? Chest 2000;118(6):15307.
58.
Pickering H, Pitcairn GR, Hirst PH, et al. Regional lung deposition of a
technetium 99m-labeled formulation of mometasone furoate administered by
hydrofluoroalkane 227 metered-dose inhaler. Clin Ther 2000;22(12):1483-93.
59.
Plint AC, Osmond MH, Klassen TP. The efficacy of nebulized racemic
epinephrine in children with acute asthma: a randomized, double-blind trial. Acad Emerg
Med 2000;7(10):1097-103.
60.
Reijonen TM, Kotaniemi-Syrjanen A, Korhonen K, Korppi M. Predictors of
asthma three years after hospital admission for wheezing in infancy. Pediatrics
2000;106(6):1406-12.
61.
Rietveld S, Everaerd W, van Beest I. Excessive breathlessness through
emotional imagery in asthma. Behav Res Ther 2000;38(10):1005-14.
62.
Rodriguez J, Crespo JF, Burks W, et al. Randomized, double-blind, crossover
challenge study in 53 subjects reporting adverse reactions to melon (Cucumis melo). J
Allergy Clin Immunol 2000;106(5):968-72.
63.
Rohatagi S, Calic F, Harding N, et al. Pharmacokinetics, pharmacodynamics,
and safety of inhaled cyclosporin A (ADI628) after single and repeated administration in
healthy male and female subjects and asthmatic patients. J Clin Pharmacol
2000;40(11):1211-26.
64.
Rytila P, Metso T, Heikkinen K, Saarelainen P, Helenius IJ, Haahtela T. Airway
inflammation in patients with symptoms suggesting asthma but with normal lung
function. Eur Respir J 2000;16(5):824-30.
65.
Scarfone RJ, Loiselle JM, Joffe MD, et al. A randomized trial of magnesium in the
emergency department treatment of children with asthma. Ann Emerg Med
2000;36(6):572-8.
66.
Shapiro G, Bronsky E, Murray A, Barnhart F, VanderMeer A, Reisner C. Clinical
comparability of ventolin formulated with hydrofluoroalkane or conventional
chlorofluorocarbon propellants in children with asthma. Arch Pediatr Adolesc Med
2000;154(12):1219-25.
67.
Stelmach I, Brzozowska A, Jerzynska J, et al. [Hypersensitivity to cockroach
allergen among children with bronchial asthma living in the Lodz district]. Pol Merkuriusz
Lek 2000;9(52):657-61.
68.
Stempel DA, Stanford RH, Thwaites R, Price MJ. Cost-efficacy comparison of
inhaled fluticasone propionate and budesonide in the treatment of asthma. Clin Ther
2000;22(12):1562-74.
69.
Stone AA, Smyth JM, Kaell A, Hurewitz A. Structured writing about stressful
events: exploring potential psychological mediators of positive health effects. Health
Psychol 2000;19(6):619-24.
70.
Storm van's Gravesande K, Mattes J, Grossklauss E, Zurmuhl A, Moseler M,
Kuhr J. Preventive effect of 2 and 10 mg of sodium cromoglycate on exercise- induced
bronchoconstriction. Eur J Pediatr 2000;159(10):759-63.
71.
Sundblad BM, Malmberg P, Larsson K. Different response to doubling and
fourfold dose increases in methacholine provocation tests in healthy subjects. Chest
2000;118(5):1371-7.
72.
Tasche MJ, Uijen JH, Bernsen RM, de Jongste JC, van der Wouden JC. Inhaled
disodium cromoglycate (DSCG) as maintenance therapy in children with asthma: a
systematic review. Thorax 2000;55(11):913-20.
73.
Taylor DR, Hancox RJ, McRae W, et al. The influence of polymorphism at
position 16 of the beta2-adrenoceptor on the development of tolerance to beta-agonist. J
Asthma 2000;37(8):691-700.
74.
Thio BJ, Slingerland GL, Fredriks AM, et al. Influence of intranasal steroids
during the grass pollen season on bronchial responsiveness in children and young
adults with asthma and hay fever. Thorax 2000;55(10):826-32.
75.
Tomalak W, Elbousefi A, Kurzawa R, Doniec Z. Diurnal variations of respiratory
system resistance and compliance derived from input impedance in asthmatic children.
Respir Physiol 2000;123(1-2):101-8.
76.
Tyminska K, Kwiatkowska S, Zieba M, et al. [Evaluation of the relationship
between the clinical course of severe asthma and ventilatory parameters]. Pol
Merkuriusz Lek 2000;9(52):653-5.
77.
Wensley D, Pickering D, Silverman M. Can peak expiratory flow be measured
accurately during a forced vital capacity manoeuvre? Eur Respir J 2000;16(4):673-6.
78.
Wilber ST, Wilson JE, Blanda M, Gerson LW, Meerbaum SO, Janas G. The
bronchodilator effect of intravenous glucagon in asthma exacerbation: a randomized,
controlled trial. Ann Emerg Med 2000;36(5):427-31.
79.
Wilson AM, Orr LC, Sims EJ, Dempsey OJ, Lipworth BJ. Antiasthmatic effects of
mediator blockade versus topical corticosteroids in allergic rhinitis and asthma. Am J
Respir Crit Care Med 2000;162(4 Pt 1):1297-301.
80.
Wolfe R, Carlin JB, Oswald H, Olinsky A, Phelan PD, Robertson CF. Association
between allergy and asthma from childhood to middle adulthood in an Australian cohort
study. Am J Respir Crit Care Med 2000;162(6):2177-81.
81.
Wu DN, Tanifuji Y, Kobayashi H, et al. Effects of esophageal acid perfusion on
airway hyperresponsiveness in patients with bronchial asthma. Chest 2000;118(6):15536.
82.
Zetterstrom O, Lahelma S, Keski-karhu J, Silvasti M, Ostling-kulling E, Ahonen A.
Salbutamol via Easyhaler is at least as effective as salbutamol via Turbuhaler in the
treatment of histamine-induced bronchoconstriction. Respir Med 2000;94(11):1097-102.
83.
Zietkowski Z, Rogalewska AM, Bodzenta LA. [The effect of local specific
bronchial immunotherapy (LIT) on specific and non-specific bronchial hyperreactivity in
patients with bronchial asthma sensitive to housedust mites]. Pol Merkuriusz Lek
2000;9(52):645-7.
84.
The safety of inactivated influenza vaccine in adults and children with asthma. N
Engl J Med 2001;345(21):1529-36.
85.
Aaron SD. The use of ipratropium bromide for the management of acute asthma
exacerbation in adults and children: a systematic review. J Asthma 2001;38(7):521-30.
86.
Adachi M, Kohno Y, Minoguchi K. Step-down and step-up therapy in moderate
persistent asthma. Int Arch Allergy Immunol 2001;124(1-3):414-6.
87.
Adams RJ, Boath K, Homan S, Campbell DA, Ruffin RE. A randomized trial of
peak-flow and symptom-based action plans in adults with moderate-to-severe asthma.
Respirology 2001;6(4):297-304.
88.
Adams RJ, Fuhlbrigge A, Finkelstein JA, et al. Impact of inhaled antiinflammatory
therapy on hospitalization and emergency department visits for children with asthma.
Pediatrics 2001;107(4):706-11.
89.
Ahrens RC, Teresi ME, Han SH, Donnell D, Vanden Burgt JA, Lux CR. Asthma
stability after oral prednisone: a clinical model for comparing inhaled steroid potency. Am
J Respir Crit Care Med 2001;164(7):1138-45.
90.
Al-Delaimy WK, Hay SM, Gain KR, Jones DT, Crane J. The effects of carbon
dioxide on exercise-induced asthma: an unlikely explanation for the effects of Buteyko
breathing training. Med J Aust 2001;174(2):72-4.
91.
Alat I, Yuksel M, Buket S, et al. The side-effects of cardiopulmonary bypass on
the lungs: changes in bronchoalveolar lavage fluids. Perfusion 2001;16(2):121-8.
92.
Alexis NE, Soukup J, Nierkens S, Becker S. Association between airway
hyperreactivity and bronchial macrophage dysfunction in individuals with mild asthma.
Am J Physiol Lung Cell Mol Physiol 2001;280(2):L369-75.
93.
Altmuller J, Palmer LJ, Fischer G, Scherb H, Wjst M. Genomewide scans of
complex human diseases: true linkage is hard to find. Am J Hum Genet 2001;69(5):93650.
94.
Amayasu H, Nakabayashi M, Akahori K, et al. Cromolyn sodium suppresses
eosinophilic inflammation in patients with aspirin-intolerant asthma. Ann Allergy Asthma
Immunol 2001;87(2):146-50.
95.
Anbar RD. Self-hypnosis for management of chronic dyspnea in pediatric
patients. Pediatrics 2001;107(2):E21.
96.
Anderson SD, Lambert S, Brannan JD, et al. Laboratory protocol for exercise
asthma to evaluate salbutamol given by two devices. Med Sci Sports Exerc
2001;33(6):893-900.
97.
Andersson F, Kjellman M, Forsberg G, Moller C, Arheden L. Comparison of the
cost-effectiveness of budesonide and sodium cromoglycate in the management of
childhood asthma in everyday clinical practice. Ann Allergy Asthma Immunol
2001;86(5):537-44.
98.
Annesi-Maesano I, Moreau D, Strachan D. In utero and perinatal complications
preceding asthma. Allergy 2001;56(6):491-7.
99.
Annus T, Bjorksten B, Mai XM, et al. Wheezing in relation to atopy and
environmental factors in Estonian and Swedish schoolchildren. Clin Exp Allergy
2001;31(12):1846-53.
100. Anstead MI, Hunt TA, McConnell JW, Jr., Burki NK. Effects of therapeutic doses
of albuterol on beta2-adrenergic receptor density and metabolic changes. J Asthma
2001;38(1):59-64.
101. Apelberg BJ, Aoki Y, Jaakkola JJ. Systematic review: Exposure to pets and risk
of asthma and asthma-like symptoms. J Allergy Clin Immunol 2001;107(3):455-60.
102. Ariano R, Spadolini I, Panzani RC. Efficacy of sublingual specific immunotherapy
in Cupressaceae allergy using an extract of Cupressus arizonica. A double blind study.
Allergol Immunopathol (Madr) 2001;29(6):238-44.
103. Arshad SH, Karmaus W, Matthews S, et al. Association of allergy-related
symptoms with sensitisation to common allergens in an adult European population. J
Investig Allergol Clin Immunol 2001;11(2):94-102.
104. Aubier M, Wettenger R, Gans SJ. Efficacy of HFA-beclomethasone dipropionate
extra-fine aerosol (800 microg day(-1)) versus HFA-fluticasone propionate (1000 microg
day(-1)) in patients with asthma. Respir Med 2001;95(3):212-20.
105. Aubier M, Neukirch C, Peiffer C, Melac M. Effect of cetirizine on bronchial
hyperresponsiveness in patients with seasonal allergic rhinitis and asthma. Allergy
2001;56(1):35-42.
106. Avital A, Uwyyed K, Berkman N, Godfrey S, Bar-Yishay E, Springer C. Exhaled
nitric oxide and asthma in young children. Pediatr Pulmonol 2001;32(4):308-13.
107. Bahceciler NN, Isik U, Barlan IB, Basaran MM. Efficacy of sublingual
immunotherapy in children with asthma and rhinitis: a double-blind, placebo-controlled
study. Pediatr Pulmonol 2001;32(1):49-55.
108. Baker D, Hann M. General practitioner services in primary care groups in
England: is there inequity between service availability and population need? Health
Place 2001;7(2):67-74.
109. Balter MS, Adams SG, Chapman KR. Inhaled beclomethasone dipropionate
improves acoustic measures of voice in patients with asthma. Chest 2001;120(6):182934.
110. Banov CH, Howland WC, 3rd, Lumry WR. Once-daily budesonide via Turbuhaler
improves symptoms in adults with persistent asthma. Ann Allergy Asthma Immunol
2001;86(6):627-32.
111. Bansal A, Farnham JM, Crapo RO, Hughes DC, Jensen RL, Cannon-Albright LA.
A simple diagnostic index for asthma. Clin Exp Allergy 2001;31(5):756-60.
112. Baren JM, Shofer FS, Ivey B, et al. A randomized, controlled trial of a simple
emergency department intervention to improve the rate of primary care follow-up for
patients with acute asthma exacerbations. Ann Emerg Med 2001;38(2):115-22.
113. Bateman ED, Silins V, Bogolubov M. Clinical equivalence of
salmeterol/fluticasone propionate in combination (50/100 microg twice daily) when
administered via a chlorofluorocarbon-free metered dose inhaler or dry powder inhaler to
patients with mild-to-moderate asthma. Respir Med 2001;95(2):136-46.
114. Belda J, Hussack P, Dolovich M, Efthimiadis A, Hargreave FE. Sputum induction:
effect of nebulizer output and inhalation time on cell counts and fluid-phase measures.
Clin Exp Allergy 2001;31(11):1740-4.
115. Benhamou D, Cuvelier A, Muir JF, et al. Rapid onset of bronchodilation in COPD:
a placebo-controlled study comparing formoterol (Foradil Aerolizer) with salbutamol
(Ventodisk). Respir Med 2001;95(10):817-21.
116. Bensch G, Lapidus RJ, Levine BE, et al. A randomized, 12-week, double-blind,
placebo-controlled study comparing formoterol dry powder inhaler with albuterol
metered-dose inhaler. Ann Allergy Asthma Immunol 2001;86(1):19-27.
117. Berend N, Kellett B, Kent N, Sly PD. Improved safety with equivalent asthma
control in adults with chronic severe asthma on high-dose fluticasone propionate.
Respirology 2001;6(3):237-46.
118. Berggren F, Ekstrom T. A cost-effectiveness study comparing the as-needed use
of formoterol (Oxis) and terbutaline (Bricanyl) in patients with moderate to severe
asthma. Respir Med 2001;95(9):753-8.
119. Bhave SY. Approach to recurrent respiratory infections. Indian J Pediatr 2001;68
Suppl 2:S26-32.
120. Bheekie A, Syce JA, Weinberg EG. Peak expiratory flow rate and symptom selfmonitoring of asthma initiated from community pharmacies. J Clin Pharm Ther
2001;26(4):287-96.
121. Bisgaard H, Price MJ, Maden C, Olsen NA. Cost-effectiveness of fluticasone
propionate administered via metered- dose inhaler plus babyhaler spacer in the
treatment of asthma in preschool-aged children. Chest 2001;120(6):1835-42.
122. Black PN, Blasi F, Jenkins CR, et al. Trial of roxithromycin in subjects with
asthma and serological evidence of infection with Chlamydia pneumoniae. Am J Respir
Crit Care Med 2001;164(4):536-41.
123. Blixen CE, Hammel JP, Murphy D, Ault V. Feasibility of a nurse-run asthma
education program for urban African- Americans: a pilot study. J Asthma 2001;38(1):2332.
124. Bond RA. Is paradoxical pharmacology a strategy worth pursuing? Trends
Pharmacol Sci 2001;22(6):273-6.
125. Borish LC, Nelson HS, Corren J, et al. Efficacy of soluble IL-4 receptor for the
treatment of adults with asthma. J Allergy Clin Immunol 2001;107(6):963-70.
126. Boulet LP, Chakir J, Milot J, Boutet M, Laviolette M. Effect of salmeterol on
allergen-induced airway inflammation in mild allergic asthma. Clin Exp Allergy
2001;31(3):430-7.
127. Braback L, Kjellman NI, Sandin A, Bjorksten B. Atopy among schoolchildren in
northern and southern Sweden in relation to pet ownership and early life events. Pediatr
Allergy Immunol 2001;12(1):4-10.
128. Brand PL, van der Baan-Slootweg OH, Heynens JW, et al. Comparison of
handling and acceptability of two spacer devices in young children with asthma. Acta
Paediatr 2001;90(2):133-6.
129. Brocklebank D, Wright J, Cates C. Systematic review of clinical effectiveness of
pressurised metered dose inhalers versus other hand held inhaler devices for delivering
corticosteroids in asthma. BMJ 2001;323(7318):896-900.
130. Brocklebank D, Ram F, Wright J, et al. Comparison of the effectiveness of inhaler
devices in asthma and chronic obstructive airways disease: a systematic review of the
literature. Health Technol Assess 2001;5(26):1-149.
131. Bronfort G, Evans RL, Kubic P, Filkin P. Chronic pediatric asthma and
chiropractic spinal manipulation: a prospective clinical series and randomized clinical
pilot study. J Manipulative Physiol Ther 2001;24(6):369-77.
132. Brooks AM, Byrd RS, Weitzman M, Auinger P, McBride JT. Impact of low birth
weight on early childhood asthma in the United States. Arch Pediatr Adolesc Med
2001;155(3):401-6.
133. Brown RH, Scichilone N, Mudge B, Diemer FB, Permutt S, Togias A. Highresolution computed tomographic evaluation of airway distensibility and the effects of
lung inflation on airway caliber in healthy subjects and individuals with asthma. Am J
Respir Crit Care Med 2001;163(4):994-1001.
134. Brygge T, Heinig JH, Collins P, et al. Reflexology and bronchial asthma. Respir
Med 2001;95(3):173-9.
135. Burggraaf J, Westendorp RG, in't Veen JC, et al. Cardiovascular side effects of
inhaled salbutamol in hypoxic asthmatic patients. Thorax 2001;56(7):567-9.
136. Busse W, Raphael GD, Galant S, et al. Low-dose fluticasone propionate
compared with montelukast for first- line treatment of persistent asthma: a randomized
clinical trial. J Allergy Clin Immunol 2001;107(3):461-8.
137. Busse W, Corren J, Lanier BQ, et al. Omalizumab, anti-IgE recombinant
humanized monoclonal antibody, for the treatment of severe allergic asthma. J Allergy
Clin Immunol 2001;108(2):184-90.
138. Busse W, Wolfe J, Storms W, et al. Fluticasone propionate compared with
zafirlukast in controlling persistent asthma: a randomized double-blind, placebocontrolled trial. J Fam Pract 2001;50(7):595-602.
139. Bynum A, Hopkins D, Thomas A, Copeland N, Irwin C. The effect of
telepharmacy counseling on metered-dose inhaler technique among adolescents with
asthma in rural Arkansas. Telemed J E Health 2001;7(3):207-17.
140. Calhoun WJ, Hinton KL, Kratzenberg JJ. The effect of salmeterol on markers of
airway inflammation following segmental allergen challenge. Am J Respir Crit Care Med
2001;163(4):881-6.
141. Capella GL, Grigerio E, Altomare G. A randomized trial of leukotriene receptor
antagonist montelukast in moderate-to-severe atopic dermatitis of adults. Eur J Dermatol
2001;11(3):209-13.
142. Carlsen KH, Hem E, Stensrud T, Held T, Herland K, Mowinckel P. Can asthma
treatment in sports be doping? The effect of the rapid onset, long-acting inhaled beta2agonist formoterol upon endurance performance in healthy well-trained athletes. Respir
Med 2001;95(7):571-6.
143. Carra S, Gagliardi L, Zanconato S, et al. Budesonide but not nedocromil sodium
reduces exhaled nitric oxide levels in asthmatic children. Respir Med 2001;95(9):734-9.
144. Carter MC, Perzanowski MS, Raymond A, Platts-Mills TA. Home intervention in
the treatment of asthma among inner-city children. J Allergy Clin Immunol
2001;108(5):732-7.
145. Casale TB, Nelson HS, Stricker WE, Raff H, Newman KB. Suppression of
hypothalamic-pituitary-adrenal axis activity with inhaled flunisolide and fluticasone
propionate in adult asthma patients. Ann Allergy Asthma Immunol 2001;87(5):379-85.
146. Cataldo D, Foidart JM, Lau L, Bartsch P, Djukanovic R, Louis R. Induced
sputum: comparison between isotonic and hypertonic saline solution inhalation in
patients with asthma. Chest 2001;120(6):1815-21.
147. Cattaneo C. Neltenexine tablets in smoking and non-smoking patients with
COPD. A double-blind, randomised, controlled study versus placebo. Minerva Med
2001;92(4):277-84.
148. Cazzola M, Centanni S, Boveri B, et al. Comparison of the bronchodilating effect
of salmeterol and zafirlukast in combination with that of their use as single treatments in
asthma and chronic obstructive pulmonary disease. Respiration 2001;68(5):452-9.
149. Chambers DC, Ayres JG. Effect of nebulised L- and D-arginine on exhaled nitric
oxide in steroid naive asthma. Thorax 2001;56(8):602-6.
150. Chan JS, Cowie RL, Lazarenko GC, Little C, Scott S, Ford GT. Comparison of
intramuscular betamethasone and oral prednisone in the prevention of relapse of acute
asthma. Can Respir J 2001;8(3):147-52.
151. Chanez P, Karlstrom R, Godard P. High or standard initial dose of budesonide to
control mild-to-moderate asthma? Eur Respir J 2001;17(5):856-62.
152. Chavasse RJ, Bastian-Lee Y, Richter H, Hilliard T, Seddon P. Persistent
wheezing in infants with an atopic tendency responds to inhaled fluticasone. Arch Dis
Child 2001;85(2):143-8.
153. Chen A, Chen R, Zhong N. [Systemic side effects of long-term treatment with low
dose inhaled corticosteroids in children with asthma]. Zhonghua Jie He He Hu Xi Za Zhi
2001;24(12):740-3.
154. Choudat D, Martin JC, Fabries JF, Villette C, Dessanges JF. [Specific bronchial
provocation test with solid aerosols. Quantification of results]. Rev Mal Respir
2001;18(2):157-62.
155. Chu HW, Kraft M, Rex MD, Martin RJ. Evaluation of blood vessels and edema in
the airways of asthma patients: regulation with clarithromycin treatment. Chest
2001;120(2):416-22.
156. Chuffart AA, Sennhauser FH, Wildhaber JH. Factors affecting the efficiency of
aerosol therapy with pressurised metered-dose inhalers through plastic spacers. Swiss
Med Wkly 2001;131(1-2):14-8.
157. Chugh K. Clinical approach to a patient with cough. Indian J Pediatr 2001;68
Suppl 2:S11-9.
158. Cibella F, Cuttitta G. Nocturnal asthma and gastroesophageal reflux. Am J Med
2001;111 Suppl 8A:31S-6S.
159. Ciprandi G, Tosca M, Passalacqua G, Canonica GW. Long-term cetirizine
treatment reduces allergic symptoms and drug prescriptions in children with mite allergy.
Ann Allergy Asthma Immunol 2001;87(3):222-6.
160. Cloosterman SG, Bijl-Hofland ID, van Herwaarden CL, et al. A placebo-controlled
clinical trial of regular monotherapy with short- acting and long-acting beta(2)-agonists in
allergic asthmatic patients. Chest 2001;119(5):1306-15.
161. Condemi JJ. Comparison of the efficacy of formoterol and salmeterol in patients
with reversible obstructive airway disease: a multicenter, randomized, open-label trial.
Clin Ther 2001;23(9):1529-41.
162. Cordina M, McElnay JC, Hughes CM. Assessment of a community pharmacybased program for patients with asthma. Pharmacotherapy 2001;21(10):1196-203.
163. Corradi M, Montuschi P, Donnelly LE, Pesci A, Kharitonov SA, Barnes PJ.
Increased nitrosothiols in exhaled breath condensate in inflammatory airway diseases.
Am J Respir Crit Care Med 2001;163(4):854-8.
164. Corren J, Nelson H, Greos LS, et al. Effective control of asthma with
hydrofluoroalkane flunisolide delivered as an extrafine aerosol in asthma patients. Ann
Allergy Asthma Immunol 2001;87(5):405-11.
165. Corren J, Spector S, Fuller L, Minkwitz M, Mezzanotte W. Effects of zafirlukast
upon clinical, physiologic, and inflammatory responses to natural cat allergen exposure.
Ann Allergy Asthma Immunol 2001;87(3):211-7.
166. Coskun S, Yuksel H, Tikiz H, Danahaliloglu S. Standard dose of inhaled albuterol
significantly increases QT dispersion compared to low dose of albuterol plus ipratropium
bromide therapy in moderate to severe acute asthma attacks in children. Pediatr Int
2001;43(6):631-6.
167. Cote J, Bowie DM, Robichaud P, Parent JG, Battisti L, Boulet LP. Evaluation of
two different educational interventions for adult patients consulting with an acute asthma
exacerbation. Am J Respir Crit Care Med 2001;163(6):1415-9.
168. Coughlan JL, Gibson PG, Henry RL. Medical treatment for reflux oesophagitis
does not consistently improve asthma control: a systematic review. Thorax
2001;56(3):198-204.
169. Craven D, Kercsmar CM, Myers TR, O'Riordan M A, Golonka G, Moore S.
Ipratropium bromide plus nebulized albuterol for the treatment of hospitalized children
with acute asthma. J Pediatr 2001;138(1):51-8.
170. Crim C, Pierre LN, Daley-Yates PT. A review of the pharmacology and
pharmacokinetics of inhaled fluticasone propionate and mometasone furoate. Clin Ther
2001;23(9):1339-54.
171. Crowell MD, Zayat EN, Lacy BE, Schettler-Duncan A, Liu MC. The effects of an
inhaled beta(2)-adrenergic agonist on lower esophageal function: a dose-response
study. Chest 2001;120(4):1184-9.
172. Custovic A, Simpson BM, Simpson A, Kissen P, Woodcock A. Effect of
environmental manipulation in pregnancy and early life on respiratory symptoms and
atopy during first year of life: a randomised trial. Lancet 2001;358(9277):188-93.
173. D'Urzo AD, Chapman KR, Cartier A, Hargreave FE, Fitzgerald M, Tesarowski D.
Effectiveness and safety of salmeterol in nonspecialist practice settings. Chest
2001;119(3):714-9.
174. Dagg KD, Clayton RA, Thomson LJ, Chalmers GW, McGrath JC, Thomson NC.
The effect of acute alteration in oxygen tension on the bronchodilator response to
salbutamol in vitro and in vivo in man. Pulm Pharmacol Ther 2001;14(2):99-105.
175. Dahlen I, Janson C, Bjornsson E, Stalenheim G, Peterson CG, Venge P.
Changes in inflammatory markers following treatment of acute exacerbations of
obstructive pulmonary disease. Respir Med 2001;95(11):891-7.
176. Dauletbaev N, Rickmann J, Viel K, Buhl R, Wagner TO, Bargon J. Glutathione in
induced sputum of healthy individuals and patients with asthma. Thorax 2001;56(1):138.
177. De Amici M, Puggioni F, Casali L, Alesina R. Variations in serum levels of
interleukin (IL)-1beta, IL-2, IL-6, and tumor necrosis factor-alpha during specific
immunotherapy. Ann Allergy Asthma Immunol 2001;86(3):311-3.
178. de Benedictis FM, Teper A, Green RJ, Boner AL, Williams L, Medley H. Effects
of 2 inhaled corticosteroids on growth: results of a randomized controlled trial. Arch
Pediatr Adolesc Med 2001;155(11):1248-54.
179. De Gouw HW, Marshall-Partridge SJ, Van Der Veen H, Van Den Aardweg JG,
Hiemstra PS, Sterk PJ. Role of nitric oxide in the airway response to exercise in healthy
and asthmatic subjects. J Appl Physiol 2001;90(2):586-92.
180. De Meer G, Heederik DJ, Brunekreef B, Postma DS. Repeatability of bronchial
hyperresponsiveness to adenosine-5'- monophosphate (AMP) by a short dosimeter
protocol. Thorax 2001;56(5):362-5.
181. Del Rio-Navarro BE, Sienra-Monge JJ, Alvarez-Amador M, Reyes-Ruiz N,
Arevalo-Salas A, Berber A. Serum potassium levels, CPK-MB and ECG in children
suffering asthma treated with beclomethasone or beclomethasone-salmeterol. Allergol
Immunopathol (Madr) 2001;29(1):16-21.
182. del-Rio-Navarro BE, Corona-Hernandez L, Fragoso-Rios R, et al. Effect of
salmeterol and salmeterol plus beclomethasone on saliva flow and IgA in patients with
moderate-persistent chronic asthma. Ann Allergy Asthma Immunol 2001;87(5):420-3.
183. Dempsey OJ, Humphreys M, Coutie WJ, Lipworth BJ. Relative lung delivery of
fluticasone propionate via large volume spacer or nebuliser in healthy volunteers. Eur J
Clin Pharmacol 2001;57(9):637-41.
184. Derom E, Borgstrom L, Van Schoor J, Lofroos AB, Pauwels R. Lung deposition
and protective effect of terbutaline delivered from pressurized metered-dose inhalers
and the Turbuhaler in asthmatic individuals. Am J Respir Crit Care Med 2001;164(8 Pt
1):1398-402.
185. Dhong HJ, Jung YS, Chung SK, Choi DC. Effect of endoscopic sinus surgery on
asthmatic patients with chronic rhinosinusitis. Otolaryngol Head Neck Surg
2001;124(1):99-104.
186. Di Franco A, Dente FL, Giannini D, et al. Effects of inhaled corticosteroids on
cough threshold in patients with bronchial asthma. Pulm Pharmacol Ther 2001;14(1):3540.
187. Dicpinigaitis PV. Effect of the cyclooxygenase-2 inhibitor celecoxib on bronchial
responsiveness and cough reflex sensitivity in asthmatics. Pulm Pharmacol Ther
2001;14(2):93-7.
188. Dolganov GM, Woodruff PG, Novikov AA, et al. A novel method of gene
transcript profiling in airway biopsy homogenates reveals increased expression of a Na+K+-Cl- cotransporter (NKCC1) in asthmatic subjects. Genome Res 2001;11(9):1473-83.
189. Dompeling E, Oudesluys-Murphy AM, Janssens HM, et al. Randomised
controlled study of clinical efficacy of spacer therapy in asthma with regard to
electrostatic charge. Arch Dis Child 2001;84(2):178-82.
190. Echazarreta AL, Gomez FP, Ribas J, et al. Pulmonary gas exchange responses
to histamine and methacholine challenges in mild asthma. Eur Respir J 2001;17(4):60914.
191. Eliraz A, Ramirez-Rivera A, Ferranti P, et al. Similar efficacy following four weeks
treatment of asthmatics with formoterol 12 micrograms b.d. delivered by two different dry
powder inhalers: differences in inhaler handling. Int J Clin Pract 2001;55(3):164-70.
192. Ellingsen I, Florvaag E, Andreassen AH, Iversen BM, Irgens A, Matre R.
Plasmapheresis in the treatment of steroid-dependent bronchial asthma. Allergy
2001;56(12):1202-5.
193. Ernst E, Harkness E. Spinal manipulation: a systematic review of shamcontrolled, double-blind, randomized clinical trials. J Pain Symptom Manage
2001;22(4):879-89.
194. Eryonucu B, Uzun K, Guler N, Bilge M. Comparison of the acute effects of
salbutamol and terbutaline on heart rate variability in adult asthmatic patients. Eur Respir
J 2001;17(5):863-7.
195. Evsiukova EV, Khavinson V, Trofimov VI, Sinitsina TM, Totoliam AA,
Bondarenko VL. [Epifamine efficacy in aspirin bronchial asthma]. Klin Med
2001;79(9):61-4.
196. Fahy JV, Boushey HA, Lazarus SC, et al. Safety and reproducibility of sputum
induction in asthmatic subjects in a multicenter study. Am J Respir Crit Care Med
2001;163(6):1470-5.
197. Fairfax A, Hall I, Spelman R. A randomized, double-blind comparison of
beclomethasone dipropionate extrafine aerosol and fluticasone propionate. Ann Allergy
Asthma Immunol 2001;86(5):575-82.
198. Fernandes AL, Faresin SM, Amorim MM, Fritscher CC, Pereira CA, Jardim JR.
Inhaled budesonide for adults with mild-to-moderate asthma: a randomized placebocontrolled, double-blind clinical trial. Sao Paulo Med J 2001;119(5):169-74.
199. Ferreira MB, Santos AS, Pregal AL, et al. Leukotriene receptor antagonists
(Montelukast) in the treatment of asthma crisis: preliminary results of a double-blind
placebo controlled randomized study. Allerg Immunol (Paris) 2001;33(8):315-8.
200. Fireman P, Prenner BM, Vincken W, Demedts M, Mol SJ, Cohen RM. Long-term
safety and efficacy of a chlorofluorocarbon-free beclomethasone dipropionate extrafine
aerosol. Ann Allergy Asthma Immunol 2001;86(5):557-65.
201. Fish JE, Israel E, Murray JJ, et al. Salmeterol powder provides significantly better
benefit than montelukast in asthmatic patients receiving concomitant inhaled
corticosteroid therapy. Chest 2001;120(2):423-30.
202. Fishwick D, Bradshaw L, Macdonald C, et al. Cumulative and single-dose design
to assess the bronchodilator effects of beta2-agonists in individuals with asthma. Am J
Respir Crit Care Med 2001;163(2):474-7.
203. Fitzmaurice GM, Laird NM, Shneyer L. An alternative parameterization of the
general linear mixture model for longitudinal data with non-ignorable drop-outs. Stat Med
2001;20(7):1009-21.
204. Foglio K, Bianchi L, Ambrosino N. Is it really useful to repeat outpatient
pulmonary rehabilitation programs in patients with chronic airway obstruction? A 2-year
controlled study. Chest 2001;119(6):1696-704.
205. Fowler SJ, Wilson AM, Griffiths EA, Lipworth BJ. Comparative in vivo lung
delivery of hydrofluoroalkane-salbutamol formulation via metered-dose inhaler alone,
with plastic spacer, or with cardboard tube. Chest 2001;119(4):1018-20.
206. Gallefoss F, Bakke PS. Cost-effectiveness of self-management in asthmatics: a
1-yr follow-up randomized, controlled trial. Eur Respir J 2001;17(2):206-13.
207. Gani F, Pozzi E, Crivellaro MA, et al. The role of patient training in the
management of seasonal rhinitis and asthma: clinical implications. Allergy
2001;56(1):65-8.
208. Gauvreau GM, Parameswaran KN, Watson RM, O'Byrne PM. Inhaled leukotriene
E(4), but not leukotriene D(4), increased airway inflammatory cells in subjects with atopic
asthma. Am J Respir Crit Care Med 2001;164(8 Pt 1):1495-500.
209. Gdalevich M, Mimouni D, Mimouni M. Breast-feeding and the risk of bronchial
asthma in childhood: a systematic review with meta-analysis of prospective studies. J
Pediatr 2001;139(2):261-6.
210. Gerhardt RT, King KM, Wiegert RS. Inhaled nitrous oxide versus placebo as an
analgesic and anxiolytic adjunct to peripheral intravenous cannulation. Am J Emerg Med
2001;19(6):492-4.
211. Gibson PG, Saltos N, Fakes K. Acute anti-inflammatory effects of inhaled
budesonide in asthma: a randomized controlled trial. Am J Respir Crit Care Med
2001;163(1):32-6.
212. Goggin N, Macarthur C, Parkin PC. Randomized trial of the addition of
ipratropium bromide to albuterol and corticosteroid therapy in children hospitalized
because of an acute asthma exacerbation. Arch Pediatr Adolesc Med
2001;155(12):1329-34.
213. Goldberg J, Freund E, Beckers B, Hinzmann R. Improved delivery of fenoterol
plus ipratropium bromide using Respimat compared with a conventional metered dose
inhaler. Eur Respir J 2001;17(2):225-32.
214. Gong H, Jr., Linn WS, Terrell SL, Anderson KR, Clark KW. Anti-inflammatory and
lung function effects of montelukast in asthmatic volunteers exposed to sulfur dioxide.
Chest 2001;119(2):402-8.
215. Goubault C, Perault MC, Leleu E, et al. Effects of inhaled salbutamol in
exercising non-asthmatic athletes. Thorax 2001;56(9):675-9.
216. Graft DF, Bernstein DI, Goldsobel A, Meltzer EO, Portnoy J, Long J. Safety of
fexofenadine in children treated for seasonal allergic rhinitis. Ann Allergy Asthma
Immunol 2001;87(1):22-6.
217. Grennan DM, Gray J, Loudon J, Fear S. Methotrexate and early postoperative
complications in patients with rheumatoid arthritis undergoing elective orthopaedic
surgery. Ann Rheum Dis 2001;60(3):214-7.
218. Griffiths C, Kaur G, Gantley M, et al. Influences on hospital admission for asthma
in south Asian and white adults: qualitative interview study. Bmj 2001;323(7319):962-6.
219. Grootendorst DC, Sterk PJ, Heijerman HG. Effect of oral prednisolone on the
bronchoprotective effect of formoterol in patients with persistent asthma. Eur Respir J
2001;17(3):374-9.
220. Grunberg K, Sharon RF, Sont JK, et al. Rhinovirus-induced airway inflammation
in asthma: effect of treatment with inhaled corticosteroids before and during
experimental infection. Am J Respir Crit Care Med 2001;164(10 Pt 1):1816-22.
221. Guilleminault C, Pelayo R, Leger D, Philip P, Ohayon M. Sleep-disordered
breathing and upper-airway anomalies in first-degree relatives of ALTE children. Pediatr
Res 2001;50(1):14-22.
222. Gutgesell C, Heise S, Seubert S, et al. Double-blind placebo-controlled house
dust mite control measures in adult patients with atopic dermatitis. Br J Dermatol
2001;145(1):70-4.
223. Haby MM, Waters E, Robertson CF, Gibson PG, Ducharme FM. Interventions for
educating children who have attended the emergency room for asthma. Cochrane
Database Syst Rev 2001;1.
224. Haneda H, Koizumi M. [Effect of FP inhalation and airway inflammation assessed
by ECP in asthma]. Nihon Kokyuki Gakkai Zasshi 2001;39(6):394-8.
225. Harish Z, Bregante AC, Morgan C, et al. A comprehensive inner-city asthma
program reduces hospital and emergency room utilization. Ann Allergy Asthma Immunol
2001;86(2):185-9.
226. Harmanci E, Colak O, Metintas M, Alatas O, Yurdasiper A. Fluticasone
propionate and budesonide do not influence bone metabolism in the long term treatment
of asthma. Allergol Immunopathol (Madr) 2001;29(1):22-7.
227. Harmanci E, Entok E, Metintas M, Vardareli E, Elbek O. Gastroesophageal reflux
in the patients with asthma. Allergol Immunopathol (Madr) 2001;29(4):123-8.
228. Harrison TW, Wisniewski A, Honour J, Tattersfield AE. Comparison of the
systemic effects of fluticasone propionate and budesonide given by dry powder inhaler in
healthy and asthmatic subjects. Thorax 2001;56(3):186-91.
229. Hegele RG, Ahmad HY, Becker AB, et al. The association between respiratory
viruses and symptoms in 2-week-old infants at high risk for asthma and allergy. J Pediatr
2001;138(6):831-7.
230. Hirono O, Kubota I, Minamihaba O, et al. Left ventricular diastolic dysfunction in
patients with bronchial asthma with long-term oral beta2-adrenoceptor agonists. Am
Heart J 2001;142(6):E11.
231. Hirst PH, Bacon RE, Pitcairn GR, Silvasti M, Newman SP. A comparison of the
lung deposition of budesonide from Easyhaler, Turbuhaler and pMDI plus spacer in
asthmatic patients. Respir Med 2001;95(9):720-7.
232. Hirst PH, Pitcairn GR, Richards JC, Rohatagi S, Gillen MS, Newman SP.
Deposition and pharmacokinetics of an HFA formulation of triamcinolone acetonide
delivered by pressurized metered dose inhaler. J Aerosol Med 2001;14(2):155-65.
233. Hnizdo E, Esterhuizen TM, Rees D, Lalloo UG. Occupational asthma as
identified by the Surveillance of Work-related and Occupational Respiratory Diseases
programme in South Africa. Clin Exp Allergy 2001;31(1):32-9.
234. Hogman M, Ludviksdottir D, Anderson SD, et al. Inhaled mannitol shifts exhaled
nitric oxide in opposite directions in asthmatics and healthy subjects. Respir Physiol
2001;124(2):141-50.
235. Holley MT, Morrissey TK, Seaberg DC, Afessa B, Wears RL. Ethical dilemmas in
a randomized trial of asthma treatment: can Bayesian statistical analysis explain the
results? Acad Emerg Med 2001;8(12):1128-35.
236. Hondras MA, Linde K, Jones AP. Manual therapy for asthma. Cochrane
Database Syst Rev 2001;1.
237. Horiguchi T, Tachikawa S, Handa M, et al. Effects of suplatast tosilate on airway
inflammation and airway hyperresponsiveness. J Asthma 2001;38(4):331-6.
238. Hoskins G, Neville R, Smith B, et al. Asthma care by nurse practitioners in the
United States. J Am Acad Nurse Pract 2001;13(8):376-83.
239. Hossn E, Mokhtar G, El-Awady M, Ali I, Morsy M, Dawood A. Environmental
exposure of the pediatric age groups in Cairo City and its suburbs to cadmium pollution.
Sci Total Environ 2001;273(1-3):135-46.
240. Htut T, Higenbottam TW, Gill GW, Darwin R, Anderson PB, Syed N. Eradication
of house dust mite from homes of atopic asthmatic subjects: a double-blind trial. J
Allergy Clin Immunol 2001;107(1):55-60.
241. Iino Y, Nagamine H, Yabe T, Matsutani S. Eosinophils are activated in middle ear
mucosa and middle ear effusion of patients with intractable otitis media associated with
bronchial asthma. Clin Exp Allergy 2001;31(7):1135-43.
242. Inman MD, Watson RM, Rerecich T, et al. Dose-dependent effects of inhaled
mometasone furoate on airway function and inflammation after allergen inhalation
challenge. Am J Respir Crit Care Med 2001;164(4):569-74.
243. Ireys HT, Chernoff R, DeVet KA, Kim Y. Maternal outcomes of a randomized
controlled trial of a community-based support program for families of children with
chronic illnesses. Arch Pediatr Adolesc Med 2001;155(7):771-7.
244. Jacobs JE, van de Lisdonk EH, Smeele I, van Weel C, Grol RP. Management of
patients with asthma and COPD: monitoring quality of life and the relationship to
subsequent GP interventions. Fam Pract 2001;18(6):574-80.
245. Janson S, Hardie G, Fahy J, Boushey H. Use of biological markers of airway
inflammation to detect the efficacy of nurse-delivered asthma education. Heart Lung
2001;30(1):39-46.
246. Jokic R, Swystun VA, Davis BE, Cockcroft DW. Regular inhaled salbutamol :
effect on airway responsiveness to methacholine and adenosine 5'-monophosphate and
tolerance to bronchoprotection. Chest 2001;119(2):370-5.
247. Jones SL, Cowan JO, Flannery EM, Hancox RJ, Herbison GP, Taylor DR.
Reversing acute bronchoconstriction in asthma: the effect of bronchodilator tolerance
after treatment with formoterol. Eur Respir J 2001;17(3):368-73.
248. Kalliomaki M, Salminen S, Arvilommi H, Kero P, Koskinen P, Isolauri E.
Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial.
Lancet 2001;357(9262):1076-9.
249. Kanniess F, Richter K, Bohme S, Jorres RA, Magnussen H. Effect of inhaled
ciclesonide on airway responsiveness to inhaled AMP, the composition of induced
sputum and exhaled nitric oxide in patients with mild asthma. Pulm Pharmacol Ther
2001;14(2):141-7.
250. Kannisto S, Korppi M, Remes K, Voutilainen R. Serum dehydroepiandrosterone
sulfate concentration as an indicator of adrenocortical suppression in asthmatic children
treated with inhaled steroids. J Clin Endocrinol Metab 2001;86(10):4908-12.
251. Karakoc F, Karadag B, Kut A, et al. A comparison of the efficacy and safety of a
half dose of fluticasone propionate with beclamethasone dipropionate and budesonide in
childhood asthma. J Asthma 2001;38(3):229-37.
252. Kassel O, de Blay F, Duvernelle C, et al. Local increase in the number of mast
cells and expression of nerve growth factor in the bronchus of asthmatic patients after
repeated inhalation of allergen at low-dose. Clin Exp Allergy 2001;31(9):1432-40.
253. Kauppinen R, Vilkka V, Sintonen H, Klaukka T, Tukiainen H. Long-term
economic evaluation of intensive patient education during the first treatment year in
newly diagnosed adult asthma. Respir Med 2001;95(1):56-63.
254. Kelloway JS, Wyatt NN, Adlis S, Schoenwetter WF. Does using a mouthwash
instead of water improve the oropharyngeal removal of inhaled flovent (fluticasone
propionate)? Allergy Asthma Proc 2001;22(6):367-71.
255. Kelloway JS WN, Adlis S, Schoenwetter WF. Does using a mouthwash instead
of water improve the oropharyngeal removal of inhaled flovent (fluticasone propionate)?
Allergy Asthma Proc. 2001 Nov-Dec;22(6):367-71. 2001.
256. Kelly KD, Spooner CH, Rowe BH. Nedocromil sodium versus sodium
cromoglycate in treatment of exercise- induced bronchoconstriction: a systematic review.
Eur Respir J 2001;17(1):39-45.
257. Kiljander T, Salomaa ER, Hietanen E, Helenius H, Liippo K, Terho EO. Asthma
and gastro-oesophageal reflux: can the response to anti-reflux therapy be predicted?
Respir Med 2001;95(5):387-92.
258. Kim CW, Kim JS, Park JW, Hong CS. Clinical applications of forced oscillation
techniques (FOT) in patients with bronchial asthma. Korean J Intern Med 2001;16(2):806.
259. Kim YK, Park HS, Kim HY, et al. Citrus red mite (Panonychus citri) may be an
important allergen in the development of asthma among exposed children. Clin Exp
Allergy 2001;31(4):582-9.
260. King GG, Moore BJ, Seow CY, Pare PD. Airway narrowing associated with
inhibition of deep inspiration during methacholine inhalation in asthmatics. Am J Respir
Crit Care Med 2001;164(2):216-8.
261. Kini NM, Robbins JM, Kirschbaum MS, Frisbee SJ, Kotagal UR. Inpatient care
for uncomplicated bronchiolitis: comparison with Milliman and Robertson guidelines.
Arch Pediatr Adolesc Med 2001;155(12):1323-7.
262. Klein JJ, van der Palen J, Uil SM, Zielhuis GA, Seydel ER, van Herwaarden CL.
Benefit from the inclusion of self-treatment guidelines to a self- management programme
for adults with asthma. Eur Respir J 2001;17(3):386-94.
263. Knorr B, Nguyen HH, Kearns GL, et al. Montelukast dose selection in children
ages 2 to 5 years: comparison of population pharmacokinetics between children and
adults. J Clin Pharmacol 2001;41(6):612-9.
264. Knorr B, Franchi LM, Bisgaard H, et al. Montelukast, a leukotriene receptor
antagonist, for the treatment of persistent asthma in children aged 2 to 5 years.
Pediatrics 2001;108(3):E48.
265. Koh YY, Sun YH, Lim HS, Kim CK, Hong SJ. Effect of inhaled budesonide on
bronchial hyperresponsiveness in adolescents with clinical remission of asthma. Chest
2001;120(4):1140-6.
266. Kon OM, Sihra BS, Loh LC, et al. The effects of an anti-CD4 monoclonal
antibody, keliximab, on peripheral blood CD4+ T-cells in asthma. Eur Respir J
2001;18(1):45-52.
267. Koppelman GH, Reijmerink NE, Colin Stine O, et al. Association of a promoter
polymorphism of the CD14 gene and atopy. Am J Respir Crit Care Med
2001;163(4):965-9.
268. Kraan J, Vink-Klooster H, Postma DS. The NK-2 receptor antagonist SR 48968C
does not improve adenosine hyperresponsiveness and airway obstruction in allergic
asthma. Clin Exp Allergy 2001;31(2):274-8.
269. Krishna MT, Chauhan A, Little L, et al. Inhibition of mast cell tryptase by inhaled
APC 366 attenuates allergen- induced late-phase airway obstruction in asthma. J Allergy
Clin Immunol 2001;107(6):1039-45.
270. Kroczynska-Bednarek J, Kwiatkowska S, Zagdanska R, Zieba M, Tyminska K,
Grzelewska-Rzymowska I. [The evaluation of efficacy and tolerability of salbutamol
administered by nebulization in patients with stable severe bronchial asthma].
Pneumonol Alergol Pol 2001;69(1-2):84-92.
271. Kunkel G, Chuchalin AG. Therapeutic equivalence of the Sofotec Novolizer to
established standard devices in COPD and asthma. Curr Opin Pulm Med 2001;7 Suppl
1:S15-7.
272. Lange J, Reihle C, Richter K, et al. [Characteristics of a target population for
preventing house-dust mite allergy in toddlers]. Gesundheitswesen 2001;63(8-9):567-72.
273. Lanz MJ, Eisenlohr C, Llabre MM, Toledo Y, Lanz MA. The effect of low-dose
inhaled fluticasone propionate on exhaled nitric oxide in asthmatic patients and
comparison with oral zafirlukast. Ann Allergy Asthma Immunol 2001;87(4):283-8.
274. Lau EM, Woo J, Chan YH, Li M. Alendronate for the prevention of bone loss in
patients on inhaled steroid therapy. Bone 2001;29(6):506-10.
275. Lau TT, Zed PJ. Does ketamine have a role in managing severe exacerbation of
asthma in adults? (Review). Pharmacotherapy 2001;21(9):1100-6.
276. Lavorini F, Fontana GA, Pantaleo T, et al. Fog-induced respiratory responses are
attenuated by nedocromil sodium in humans. Am J Respir Crit Care Med
2001;163(5):1117-20.
277. Lazarus SC, Boushey HA, Fahy JV, et al. Long-acting beta2-agonist
monotherapy vs continued therapy with inhaled corticosteroids in patients with persistent
asthma: a randomized controlled trial. Jama 2001;285(20):2583-93.
278. Leflein JG, Gawchik SM, Galant SP, et al. Safety of budesonide inhalation
suspension (Pulmicort Respules) after up to 52 weeks of treatment in infants and young
children with persistent asthma. Allergy Asthma Proc 2001;22(6):359-66.
279. Lemanske RF, Jr., Sorkness CA, Mauger EA, et al. Inhaled corticosteroid
reduction and elimination in patients with persistent asthma receiving salmeterol: a
randomized controlled trial. Jama 2001;285(20):2594-603.
280. Leuppi JD, Schnyder P, Hartmann K, Reinhart WH, Kuhn M. Drug-induced
bronchospasm: analysis of 187 spontaneously reported cases. Respiration
2001;68(4):345-51.
281. Levy S, Volans G. The use of analgesics in patients with asthma. Drug Saf
2001;24(11):829-41.
282. Liebke C, Sommerfeld C, Wahn U, Niggemann B. [Preventive monotherapy with
montelukast versus DNCG in children with mild asthma. Results of and exploratory pilot
study]. Pneumologie 2001;55(5):231-7.
283. Lim S, Tomita K, Carramori G, et al. Low-dose theophylline reduces eosinophilic
inflammation but not exhaled nitric oxide in mild asthma. Am J Respir Crit Care Med
2001;164(2):273-6.
284. Linde K, Jonas WB, Melchart D, Willich S. The methodological quality of
randomized controlled trials of homeopathy, herbal medicines and acupuncture. Int J
Epidemiol 2001;30(3):526-31.
285. Lis G, Cichocka-Jarosz E, Glodzik I, Szczerbinski T, Bialoruska B. [Montelukast
in treatment mild chronic asthma]. Pneumonol Alergol Pol 2001;69(5-6):257-64.
286. Liu C, Feekery C. Can asthma education improve clinical outcomes? An
evaluation of a pediatric asthma education program. J Asthma 2001;38(3):269-78.
287. Liu MC, Proud D, Lichtenstein LM, et al. Effects of prednisone on the cellular
responses and release of cytokines and mediators after segmental allergen challenge of
asthmatic subjects. J Allergy Clin Immunol 2001;108(1):29-38.
288. Loew TH, Tritt K, Siegfried W, Bohmann H, Martus P, Hahn EG. Efficacy of
'functional relaxation' in comparison to terbutaline and a 'placebo relaxation' method in
patients with acute asthma. A randomized, prospective, placebo-controlled, crossover
experimental investigation. Psychother Psychosom 2001;70(3):151-7.
289. Lonnkvist K, Hellman C, Lundahl J, Hallden G, Hedlin G. Eosinophil markers in
blood, serum, and urine for monitoring the clinical course in childhood asthma: impact of
budesonide treatment and withdrawal. J Allergy Clin Immunol 2001;107(5):812-7.
290. Lotvall J, Palmqvist M, Arvidsson P, Maloney A, Ventresca GP, Ward J. The
therapeutic ratio of R-albuterol is comparable with that of RS-albuterol in asthmatic
patients. J Allergy Clin Immunol 2001;108(5):726-31.
291. Lucas-Bouwman ME, Roorda RJ, Jansman FG, Brand PL. Crushed prednisolone
tablets or oral solution for acute asthma? Arch Dis Child 2001;84(4):347-8.
292. Lumry W, Noveck R, Weinstein S, et al. Switching from Ventolin CFC to Ventolin
HFA is well tolerated and effective in patients with asthma. Ann Allergy Asthma Immunol
2001;86(3):297-303.
293. Magadle R, Berar-Yanay N, Weiner P. Long-acting bronchodilators in
premenstrual exacerbation of asthma. Respir Med 2001;95(9):740-3.
294. Mallol J, Aguirre V, Rhem R, Rodriguez J, Dolovich M. Therapeutic equivalence
of three metered-dose inhalers containing salbutamol (Albuterol) in protecting against
methacholine-induced bronchoconstriction in children with asthma. Pediatr Pulmonol
2001;32(6):447-52.
295. Martin Olmedo P, Leon Jimenez A, Benitez Rodrigueza E, Gomez Gutierrez JM,
Mangas Rojas A. [Comparison of two models of education for asthmatic patients]. Med
Clin (Barc) 2001;116(11):408-12.
296. Mathes DD, Conaway MR, Ross WT. Ambulatory surgery: room air versus nasal
cannula oxygen during transport after general anesthesia. Anesth Analg 2001;93(4):91721.
297. Matthys H, Giebelhaus V, von Fallois J. [Nebivolol (nebilet) a beta blocker of the
third generation--also for patients with obstructive lung diseases?]. Z Kardiol
2001;90(10):760-5.
298. Matz J, Emmett A, Rickard K, Kalberg C. Addition of salmeterol to low-dose
fluticasone versus higher-dose fluticasone: an analysis of asthma exacerbations. J
Allergy Clin Immunol 2001;107(5):783-9.
299. McCarty JM, Pierce PF. Five days of cefprozil versus 10 days of clarithromycin in
the treatment of an acute exacerbation of chronic bronchitis. Ann Allergy Asthma
Immunol 2001;87(4):327-34.
300. McCowan C, Neville RG, Ricketts IW, Warner FC, Hoskins G, Thomas GE.
Lessons from a randomized controlled trial designed to evaluate computer decision
support software to improve the management of asthma. Med Inform Internet Med
2001;26(3):191-201.
301. Meyer JD, Holt DL, Chen Y, Cherry NM, McDonald JC. SWORD '99: surveillance
of work-related and occupational respiratory disease in the UK. Occup Med (Lond)
2001;51(3):204-8.
302. Mickleborough TD, Gotshall RW, Cordain L, Lindley M. Dietary salt alters
pulmonary function during exercise in exercise-induced asthmatics. J Sports Sci
2001;19(11):865-73.
303. Mickleborough TD, Gotshall RW, Kluka EM, Miller CW, Cordain L. Dietary
chloride as a possible determinant of the severity of exercise-induced asthma. Eur J
Appl Physiol 2001;85(85(5)).
304. Mihrshahi S, Peat JK, Webb K, et al. The childhood asthma prevention study
(CAPS): design and research protocol of a randomized trial for the primary prevention of
asthma. Control Clin Trials 2001;22(3):333-54.
305. Milgrom H, Berger W, Nayak A, et al. Treatment of childhood asthma with antiimmunoglobulin E antibody (omalizumab). Pediatrics 2001;108(2):E36.
306. Milgrom H, Skoner DP, Bensch G, Kim KT, Claus R, Baumgartner RA. Low-dose
levalbuterol in children with asthma: safety and efficacy in comparison with placebo and
racemic albuterol. J Allergy Clin Immunol 2001;108(6):938-45.
307. Mineev VH, Bulatova N. [Effects of glucose inhalations on bronchial reactivity in
bronchial asthma]. Klin Med 2001;79(8):37-9.
308. Miyamoto T, Takahashi T, Nakajima S, et al. Efficacy of budesonide Turbuhaler
compared with that of beclomethasone dipropionate pMDI in Japanese patients with
moderately persistent asthma. Respirology 2001;6(1):27-35.
309. Molimard M, Bourcereau J, Le Gros V, Bourdeix I, Leynadier F, Duroux P.
Comparison between formoterol 12 microg b.i.d. and on-demand salbutamol in
moderate persistent asthma. Respir Med 2001;95(1):64-70.
310. Montnemery P, Svensson C, Adelroth E, et al. Prevalence of nasal symptoms
and their relation to self-reported asthma and chronic bronchitis/emphysema. Eur Respir
J 2001;17(4):596-603.
311. Morali T, Yilmaz A, Erkan F, Akkaya E, Ece F, Baran R. Efficacy of inhaled
budesonide and oral theophylline in asthmatic subjects. J Asthma. J Asthma
2001;38(8):673-9.
312. Morgan TO, Anderson AI, MacInnis RJ. ACE inhibitors, beta-blockers, calcium
blockers, and diuretics for the control of systolic hypertension. Am J Hypertens
2001;14(3):241-7.
313. Morice AH, Wrench C. The role of the asthma nurse in treatment compliance and
self-management following hospital admission. Respir Med 2001;95(11):851-6.
314. Morris A, Noakes M, Clifton PM. The role of n-6 polyunsaturated fat in stable
asthmatics. J Asthma 2001;38(4):311-9.
315. Mudway IS, Stenfors N, Blomberg A, et al. Differences in basal airway
antioxidant concentrations are not predictive of individual responsiveness to ozone: a
comparison of healthy and mild asthmatic subjects. Free Radic Biol Med
2001;31(8):962-74.
316. Mungan D, Bavbek S, Peksari V, Celik G, Gugey E, Misirligil Z. Trichophyton
sensitivity in allergic and nonallergic asthma. Allergy 2001;56(6):558-62.
317. Munks-Lederer C, Dhein Y, Richter B, Worth H. [Evaluation of a structured
education program for adult outpatient asthmatics]. Pneumologie 2001;55(2):84-90.
318. Muzembo Ndundu J, Nkakudulu Bikuku H, Frans A. [Respiratory rehabilitation in
patients with bronchial asthma and chronic obstructive pulmonary disease (COPD) in
Kinshasa]. Rev Pneumol Clin 2001;57(3):209-18.
319. Myou S, Fujimura M, Kamio Y, et al. Effect of a cysteinyl leukotriene antagonist,
pranlukast hydrate, on acetaldehyde-induced bronchoconstriction in asthmatic patients.
Prostaglandins Leukot Essent Fatty Acids 2001;65(1):41-4.
320. Narhi U, Airaksinen M, Tanskanen P, Enlund H. The effects of a pharmacybased intervention on the knowledge and attitudes of asthma patients. Patient Educ
Couns 2001;43(2):171-7.
321. Nathan RA, Nayak AS, Graft DF, et al. Mometasone furoate: efficacy and safety
in moderate asthma compared with beclomethasone dipropionate. Ann Allergy Asthma
Immunol 2001;86(2):203-10.
322. Nathan RA, Bleecker ER, Kalberg C. A comparison of short-term treatment with
inhaled fluticasone propionate and zafirlukast for patients with persistent asthma. Am J
Med 2001;111(3):195-202.
323. Nell H, Louw CM, Cyster H, Williams Z, Bardin PG, Joubert JR. Therapeutic
equivalence study of two formulations (innovator v. generic) of beclomethasone
dipropionate in adult asthmatic patients. S Afr Med J 2001;91(1):51-6.
324. Newman SP, Pitcairn GR, Adkin DA, Vidgren MT, Silvasti M. Comparison of
beclomethasone dipropionate delivery by easyhaler dry powder inhaler and pMDI plus
large volume spacer. J Aerosol Med 2001;14(2):217-25.
325. Newman AB, Naydeck BL, Sutton-Tyrrell K, Feldman A, Edmundowicz D, Kuller
LH. Coronary artery calcification in older adults to age 99: prevalence and risk factors.
Circulation 2001;104(22):2679-84.
326. Nielsen KG, Bisgaard H. Bronchodilation and bronchoprotection in asthmatic
preschool children from formoterol administered by mechanically actuated dry-powder
inhaler and spacer. Am J Respir Crit Care Med 2001;164(2):256-9.
327. Nielsen KG, Bisgaard H. Discriminative capacity of bronchodilator response
measured with three different lung function techniques in asthmatic and healthy children
aged 2 to 5 years. Am J Respir Crit Care Med 2001;164(4):554-9.
328. Nikitin AV, Zuikova AA. [Clinical effectiveness of superoxide inhalations and their
effects on crystalline structure and antiradical defense of blood serum and expired air
condensate in patients with bronchial asthma]. Ter Arkh 2001;73(3):20-3.
329. Nishimura Y, Yu Y, Kotani Y, et al. Bronchial hyperresponsiveness and exhaled
nitric oxide in patients with cardiac disease. Respiration 2001;68(1):41-5.
330. Noga O, Hanf G, Schaper C, O'Connor A, Kunkel G. The influence of inhalative
corticosteroids on circulating Nerve Growth Factor, Brain-Derived Neurotrophic Factor
and Neurotrophin-3 in allergic asthmatics. Clin Exp Allergy 2001;31(12):1906-12.
331. Nong BR, Huang YF, Hsieh KS, et al. A comparison of clinical use of fluticasone
propionate and beclomethasone dipropionate in pediatric asthma. Kaohsiung J Med Sci
2001;17(6):302-11.
332. Noonan M, Karpel JP, Bensch GW, et al. Comparison of once-daily to twice-daily
treatment with mometasone furoate dry powder inhaler. Ann Allergy Asthma Immunol
2001;86(1):36-43.
333. Nuhoglu Y, Bahceciler NN, Barlan IB, Mujdat Basaran M. The effectiveness of
high-dose inhaled budesonide therapy in the treatment of acute asthma exacerbations in
children. Ann Allergy Asthma Immunol 2001;86(3):318-22.
334. O'Byrne PM, Barnes PJ, Rodriguez-Roisin R, et al. Low dose inhaled budesonide
and formoterol in mild persistent asthma: the OPTIMA randomized trial. Am J Respir Crit
Care Med 2001;164(8 Pt 1):1392-7.
335. O'Connor B, Bonnaud G, Haahtela T, et al. Dose-ranging study of mometasone
furoate dry powder inhaler in the treatment of moderate persistent asthma using
fluticasone propionate as an active comparator. Ann Allergy Asthma Immunol
2001;86(4):397-404.
336. Obase Y, Shimoda T, Tomari S, et al. Efficacy and safety of long-term treatment
of asthmatic patients with pranlukast, a cysteinyl-leukotriene-receptor antagonist: fouryear followup study. Ann Allergy Asthma Immunol 2001;87(1):43-7.
337. Oldfield WL, Kay AB, Larche M. Allergen-derived T cell peptide-induced late
asthmatic reactions precede the induction of antigen-specific hyporesponsiveness in
atopic allergic asthmatic subjects. J Immunol 2001;167(3):1734-9.
338. Oliver B, Tomita K, Keller A, et al. Low-dose theophylline does not exert its antiinflammatory effects in mild asthma through upregulation of interleukin-10 in alveolar
macrophages. Allergy 2001;56(11):1087-90.
339. Orsida BE, Ward C, Li X, et al. Effect of a long-acting beta2-agonist over three
months on airway wall vascular remodeling in asthma. Am J Respir Crit Care Med
2001;164(1):117-21.
340. Palmqvist M, Arvidsson P, Beckman O, Peterson S, Lotvall J. Onset of
bronchodilation of budesonide/formoterol vs. salmeterol/fluticasone in single inhalers.
Pulm Pharmacol Ther 2001;14(1):29-34.
341. Palmqvist M, Cui ZH, Sjostrand M, Linden A, Lotvall J. Reduced late asthmatic
response by repeated low-dose allergen exposure. Eur Respir J 2001;17(5):872-80.
342. Panicker J, Sethi GR, Sehgal V. Comparative efficiency of commercial and
improvised spacer device in acute bronchial asthma. Indian Pediatr 2001;38(4):340-8.
343. Park HS, Nahm DH, Kim HY, et al. Clinical and immunologic changes after
allergen immunotherapy with Hop Japanese pollen. Ann Allergy Asthma Immunol
2001;86(4):444-8.
344. Pelkonen AS, Hakulinen AL, Hallman M, Turpeinen M. Effect of inhaled
budesonide therapy on lung function in schoolchildren born preterm. Respir Med
2001;95(7):565-70.
345. Pellegrino R, Biggi A, Papaleo A, Camuzzini G, Rodarte JR, Brusasco V.
Regional expiratory flow limitation studied with Technegas in asthma. J Appl Physiol
2001;91(5):2190-8.
346. Persiani S, D'Amato M, Makovec F, Arshad SH, Holgate ST, Rovati LC.
Pharmacokinetics of andolast after administration of single escalating doses by
inhalation in mild asthmatic patients. Biopharm Drug Dispos 2001;22(2):73-81.
347. Peters EA, Hiltermann JT, Stolk J. Effect of apocynin on ozone-induced airway
hyperresponsiveness to methacholine in asthmatics. Free Radic Biol Med
2001;31(11):1442-7.
348. Petersen H, Kullberg A, Edsbacker S, Greiff L. Nasal retention of budesonide
and fluticasone in man: formation of airway mucosal budesonide-esters in vivo. Br J Clin
Pharmacol 2001;51(2):159-63.
349. Pichler CE, Helbling A, Pichler WJ. Three years of specific immunotherapy with
house-dust-mite extracts in patients with rhinitis and asthma: significant improvement of
allergen- specific parameters and of nonspecific bronchial hyperreactivity. Allergy
2001;56(4):301-6.
350. Pitten FA, Scholler M, Kruger U, Effendy I, Kramer A. Filamentous fungi and
yeasts on mattresses covered with different encasings. Eur J Dermatol 2001;11(6):5347.
351. Porter RS, Nester, Braitman LE, Geary U, Dalsey WC. Intravenous magnesium
is ineffective in adult asthma, a randomized trial. Eur J Emerg Med 2001;8(1):9-15.
352. Postma DS, Sevette C, Martinat Y, Schlosser N, Aumann J, Kafe H. Treatment of
asthma by the inhaled corticosteroid ciclesonide given either in the morning or evening.
Eur Respir J 2001;17(6):1083-8.
353. Pronk-Admiraal CJ, Haitjema T, Horikx P, Bartels PC. Surplus value of eosinophil
count and ECP to diagnose and monitor asthmatic patients. Neth J Med 2001;58(1):917.
354. Qureshi F, Zaritsky A, Poirier MP. Comparative efficacy of oral dexamethasone
versus oral prednisone in acute pediatric asthma. J Pediatr 2001;139(1):20-6.
355. Radon K, Danuser B, Iversen M, et al. Respiratory symptoms in European animal
farmers. Eur Respir J 2001;17(4):747-54.
356. Rak S, Heinrich C, Jacobsen L, Scheynius A, Venge P. A double-blinded,
comparative study of the effects of short preseason specific immunotherapy and topical
steroids in patients with allergic rhinoconjunctivitis and asthma. J Allergy Clin Immunol
2001;108(6):921-8.
357. Ram FS, Wright J, Brocklebank D, White JE. Systematic review of clinical
effectiveness of pressurised metered dose inhalers versus other hand held inhaler
devices for delivering beta (2 )agonists bronchodilators in asthma. Bmj
2001;323(7318):901-5.
358. Ramadan HH. Corticosteroid therapy during endoscopic sinus surgery in
children: is there a need for a second look? Arch Otolaryngol Head Neck Surg
2001;127(2):188-92.
359. Ream RS, Loftis LL, Albers GM, Becker BA, Lynch RE, Mink RB. Efficacy of IV
theophylline in children with severe status asthmaticus. Chest 2001;119(5):1480-8.
360. Redington AE, Meng QH, Springall DR, et al. Increased expression of inducible
nitric oxide synthase and cyclo- oxygenase-2 in the airway epithelium of asthmatic
subjects and regulation by corticosteroid treatment. Thorax 2001;56(5):351-7.
361. Reichel W, Dahl R, Ringdal N, Zetterstrom O, van den Elshout FJ, Laitinen LA.
Extrafine beclomethasone dipropionate breath-actuated inhaler (400 micrograms/day)
versus budesonide dry powder inhaler (800 micrograms/day) in asthma. Int J Clin Pract
2001;55(2):100-6.
362. Richards J, Hirst P, Pitcairn G, et al. Deposition and pharmacokinetics of
flunisolide delivered from pressurized inhalers containing non-CFC and CFC propellants.
J Aerosol Med 2001;14(2):197-208.
363. Ringsberg KC, Timpka T. Clinical health education for patients with asthma-like
symptoms but negative asthma tests. Allergy 2001;56(11):1049-54.
364. Robinson DS, Campbell D, Barnes PJ. Addition of leukotriene antagonists to
therapy in chronic persistent asthma: a randomised double-blind placebo-controlled trial.
Lancet 2001;357(9273):2007-11.
365. Rodrigo G, Rodrigo C, Pollack C, Travers A. Helium-oxygen mixture for
nonintubated acute asthma patients. Cochrane Database Syst Rev 2001;1.
366. Roorda RJ, Mezei G, Bisgaard H, Maden C. Response of preschool children with
asthma symptoms to fluticasone propionate. J Allergy Clin Immunol 2001;108(4):540-6.
367. Rowe BH, Edmonds ML, Spooner CH, Camargo CA. Evidence-based treatments
for acute asthma. Respir Care 2001;46(12):1380-90; discussion 90-1.
368. Ruffin R, Wilson D, Smith B, Southcott A, Adams R. Prevalence, morbidity and
management of adult asthma in South Australia. Immunol Cell Biol 2001;79(2):191-4.
369. Sanchez Palacios A, Schamann F, Garcia JA. [Sublingual immunotherapy with
cat epithelial extract. Personal experience]. Allergol Immunopathol (Madr)
2001;29(2):60-5.
370. Sangwan S, Agosti JM, Bauer LA, et al. Aerosolized protein delivery in asthma:
gamma camera analysis of regional deposition and perfusion. J Aerosol Med
2001;14(2):185-95.
371. Savva K, Rosen EU, Bolton KD, Thein O, Mayet Z. Effect of the whistle watch
device on bronchodilator use in children with asthma. S Afr Med J 2001;91(3):234-7.
372. Scalfaro P, Sly PD, Sims C, Habre W. Salbutamol prevents the increase of
respiratory resistance caused by tracheal intubation during sevoflurane anesthesia in
asthmatic children. Anesth Analg 2001;93(4):898-902.
373. Schenk P, Vonbank K, Schnack B, Haber P, Lehr S, Smetana R. Intravenous
magnesium sulfate for bronchial hyperreactivity: a randomized, controlled, double-blind
study. Clin Pharmacol Ther 2001;69(5):365-71.
374. Schmidt BM, Kusma M, Feuring M, et al. The phosphodiesterase 4 inhibitor
roflumilast is effective in the treatment of allergic rhinitis. J Allergy Clin Immunol
2001;108(4):530-6.
375. Schulz M, Verheyen F, Muhlig S, et al. Pharmaceutical care services for asthma
patients: a controlled intervention study. J Clin Pharmacol 2001;41(6):668-76.
376. Scott MB, Ellis MH, Cruz-Rivera M, Fitzpatrick S, Smith JA. Once-daily
budesonide inhalation suspension in infants and children < 4 and > or = 4 years of age
with persistent asthma. Ann Allergy Asthma Immunol 2001;87(6):488-95.
377. Scribano PV, Lerer T, Kennedy D, Cloutier MM. Provider adherence to a clinical
practice guideline for acute asthma in a pediatric emergency department. Acad Emerg
Med 2001;8(12):1147-52.
378. Seddon ME, Marshall MN, Campbell SM, Roland MO. Systematic review of
studies of quality of clinical care in general practice in the UK, Australia and New
Zealand. Qual Health Care 2001;10(3):152-8.
379. Segura Mendez N, Espinola Reyna G, Juarez Morales D, et al. [Results of an
educational program for adults with asthma]. Rev Alerg Mex 2001;48(6):152-5.
380. Seppala OR, Aalto E, Annila, et al. The efficacy of a new salbutamol metereddose powder inhaler in comparison with two other inhaler devices. Respir Med
2001;95(12):949-53.
381. Shah S, Peat JK, Mazurski EJ, et al. Effect of peer led programme for asthma
education in adolescents: cluster randomised controlled trial. BMJ 2001;322(7286):5835.
382. Shapiro GG, Mendelson LM, Pearlman DS. Once-daily budesonide inhalation
powder (Pulmicort Turbuhaler) maintains pulmonary function and symptoms of asthmatic
children previously receiving inhaled corticosteroids. Ann Allergy Asthma Immunol
2001;86(6):633-40.
383. Sharma A, Madan A. Subcutaneous epinephrine vs nebulized salbutamol in
asthma. Indian J Pediatr 2001;68(12):1127-30.
384. Shegog R, Bartholomew LK, Parcel GS, Sockrider MM, Masse L, Abramson SL.
Impact of a computer-assisted education program on factors related to asthma selfmanagement behavior. J Am Med Inform Assoc 2001;8(1):49-61.
385. Sheikh S, Null D, Gentile D, et al. Urinary leukotriene E(4) excretion during the
first month of life and subsequent bronchopulmonary dysplasia in premature infants.
Chest 2001;119(6):1749-54.
386. Shirtcliffe PM, Easthope SE, Cheng S, et al. The effect of delipidated
deglycolipidated (DDMV) and heat-killed Mycobacterium vaccae in asthma. Am J Respir
Crit Care Med 2001;163(6):1410-4.
387. Silkoff PE, McClean P, Spino M, Erlich L, Slutsky AS, Zamel N. Dose-response
relationship and reproducibility of the fall in exhaled nitric oxide after inhaled
beclomethasone dipropionate therapy in asthma patients. Chest 2001;119(5):1322-8.
388. Silvestri M, Spallarossa D, Battistini E, Fregonese B, Rossi GA. How can we best
read exhaled nitric oxide flow curves in asthmatic children? Monaldi Arch Chest Dis
2001;56(5):384-9.
389. Simonenko VB, Boitsov SA, Kuchmin AN, Nedoshvin K. [Characteristics of
arrhythmias and their treatment with diltiazem in patients with bronchial asthma]. Klin
Med 2001;79(3):22-6.
390. Singh M, Kumar L. Randomized comparison of a dry powder inhaler and metered
dose inhaler with spacer in management of children with asthma. Indian Pediatr
2001;38(1):24-8.
391. Singhal T, Garg H, Arora HS, Lodha R, Pandey RM, Kabra SK. Efficacy of a
home-made spacer with acute exacerbation of bronchial asthma: a randomized
controlled trial. Indian J Pediatr 2001;68(1):37-40.
392. Sivri A, Coplu L. Effect of the long-term use of inhaled corticosteroids on bone
mineral density in asthmatic women. Respirology 2001;6(2):131-4.
393. Slatinova OV, Mokronosova MA, Skhodova SA, Krasnoproshina LI. [Humoral
immune response in patients with bronchopulmanory infections to immunotherapy]. Zh
Mikrobiol Epidemiol Immunobiol 2001(2):49-53.
394. Soler M, Matz J, Townley R, et al. The anti-IgE antibody omalizumab reduces
exacerbations and steroid requirement in allergic asthmatics. Eur Respir J
2001;18(2):254-61.
395. Sosa M, Flores G, Estrada S, Orea M, Gomez Vera J. [Comparative treatment
between thalidomide and transfer factor in severe atopic dermatitis]. Rev Alerg Mex
2001;48(2):56-64.
396. Spahn JD, Fost DA, Covar R, et al. Clarithromycin potentiates glucocorticoid
responsiveness in patients with asthma: results of a pilot study. Ann Allergy Asthma
Immunol 2001;87(6):501-5.
397. Stelmach I, Jerzynska J, Brzozowska A, Kuna P. Double-blind, randomized,
placebo-controlled trial of effect of nedocromil sodium on clinical and inflammatory
parameters of asthma in children allergic to dust mite. Allergy 2001;56(6):518-24.
398. Stelmach I, Grzelewski T, Majak P, et al. [The effect of triamcinolone,
montelukast and formoterol on serum levels of il-4, IgE and clinical parameters in
children with asthma]. Pol Merkuriusz Lek 2001;11(63):247-51.
399. Stempel DA, Mauskopf J, McLaughlin T, Yazdani C, Stanford RH. Comparison of
asthma costs in patients starting fluticasone propionate compared to patients starting
montelukast. Respir Med 2001;95(3):227-34.
400. Stevenson DD, Simon RA. Lack of cross-reactivity between rofecoxib and aspirin
in aspirin-sensitive patients with asthma. J Allergy Clin Immunol 2001;108(1):47-51.
401. Sundblad BM, Malmberg P, Larsson K. Comparison of airway conductance and
FEV(1) as measures of airway responsiveness to methacholine. Discrimination of small
differences in bronchial responsiveness with Gaw and FEV(1). Clin Physiol
2001;21(6):673-81.
402. Sunyer J, Mendendez C, Ventura PJ, et al. Prenatal risk factors of wheezing at
the age of four years in Tanzania. Thorax 2001;56(4):290-5.
403. Sunyer J, Anto JM, Harris J, et al. Maternal atopy and parity. Clin Exp Allergy
2001;31(9):1352-5.
404. Szczeklik A, Nizankowska E, Bochenek G, Nagraba K, Mejza F, Swierczynska
M. Safety of a specific COX-2 inhibitor in aspirin-induced asthma. Clin Exp Allergy
2001;31(2):219-25.
405. Tamaoki J, Kondo M, Kuroda H, et al. Validity and safety of sputum induction by
inhaled uridine 5'-triphosphate. Am J Respir Crit Care Med 2001;164(3):378-81.
406. Tanaka H, Teramoto S, Oashi K, et al. Effects of candesartan on cough and
bronchial hyperresponsiveness in mildly to moderately hypertensive patients with
symptomatic asthma. Circulation 2001;104(3):281-5.
407. Tang RB, Chen SJ. Soluble interleukin-2 receptor and interleukin-4 in sera of
asthmatic children before and after a prednisolone course. Ann Allergy Asthma Immunol
2001;86(3):314-7.
408. Tarasova OV. [Clinical and immunologic effect of likopid in complex therapy of
occupational bronchial asthma]. Med Tr Prom Ekol 2001;11:31-4.
409. Tattersfield AE, Town GI, Johnell O, et al. Bone mineral density in subjects with
mild asthma randomised to treatment with inhaled corticosteroids or non-corticosteroid
treatment for two years. Thorax 2001;56(4):272-8.
410. Tattersfield AE, Lofdahl CG, Postma DS, et al. Comparison of formoterol and
terbutaline for as-needed treatment of asthma: a randomised trial. Lancet
2001;357(9252):257-61.
411. Terzano C, Guerra S, Allegra L. Effectiveness of beclomethasone dipropionate
aerosolized through different nebulizers to asthmatic patients. Eur Rev Med Pharmacol
Sci 2001;5(2):43-51.
412. Terzano C, Allegra L, Barkai L, Cremonesi G. Beclomethasone dipropionate
versus budesonide inhalation suspension in children with mild to moderate persistent
asthma. Eur Rev Med Pharmacol Sci 2001;5(1):17-24.
413. Terzano C, Barkai L, Cremonesi G. Corticosteroids administered by nebulization
to children with bronchial asthma. Adv Ther 2001;18(6):253-60.
414. Thio BJ, Slingerland GL, Nagelkerke AF, Roord JJ, Mulder PG, Dankert-Roelse
JE. Effects of single-dose fluticasone on exercise-induced asthma in asthmatic children:
a pilot study. Pediatr Pulmonol 2001;32(2):115-21.
415. Thoren P, Wallin A, Whitehead PJ, Sandstrom T. The effect of different
concentrations of lactose powder on the airway function of adult asthmatics. Respir Med
2001;95(11):870-5.
416. Thorsson L, Edsbacker S, Kallen A, Lofdahl CG. Pharmacokinetics and systemic
activity of fluticasone via Diskus and pMDI, and of budesonide via Turbuhaler. Br J Clin
Pharmacol 2001;52(5):529-38.
417. Tomari S, Shimoda T, Kawano T, et al. Effects of pranlukast, a cysteinyl
leukotriene receptor 1 antagonist, combined with inhaled beclomethasone in patients
with moderate or severe asthma. Ann Allergy Asthma Immunol 2001;87(2):156-61.
418. Torres-Galvan MJ, Ortega N, Sanchez-Garcia F, Blanco C, Carrillo T, Quiralte J.
LTC4-synthase A-444C polymorphism: lack of association with NSAID-induced isolated
periorbital angioedema in a Spanish population. Ann Allergy Asthma Immunol
2001;87(6):506-10.
419. Tovt-Korshyns'ka MI, Spivak M, Chopei IV, et al. [Clinical study of antileukotriene therapy with montelukast in bronchial asthma patients]. Lik Sprava
2001(4):157-9.
420. Tranfa CM, Vatrella A, Parrella R, Pelaia G, Bariffi F, Marsico SA. Effect of
inhaled heparin on water-induced bronchoconstriction in allergic asthmatics. Eur J Clin
Pharmacol 2001;57(1):5-9.
421. Travers A, Jones AP, Kelly K, Barker SJ, Camargo CA, Rowe BH. Intravenous
beta2-agonists for acute asthma in the emergency department. Cochrane Database Syst
Rev 2001;2.
422. Trenga CA, Koenig JQ, Williams PV. Dietary antioxidants and ozone-induced
bronchial hyperresponsiveness in adults with asthma. Arch Environ Health
2001;56(3):242-9.
423. Tsai JJ, Chan SC, Ho CK, Su YC, Feng TC. Efficacy of zafirlukast in the
treatment of patients with bronchial asthma. J Microbiol Immunol Infect 2001;34(1):6370.
424. Tunnicliffe WS, Evans DE, Mark D, Harrison RM, Ayres JG. The effect of
exposure to sulphuric acid on the early asthmatic response to inhaled grass pollen
allergen. Eur Respir J 2001;18(4):640-6.
425. Tutluoglu B, Gurbuz N, Atis S, Abanozlu S, Ibis R, Kanik A. Effects of heparin on
hypertonic potassium chloride-induced bronchoconstriction. Ann Pharmacother
2001;35(10):1161-5.
426. Vagaggini B, Taccola M, Conti I, et al. Budesonide reduces neutrophilic but not
functional airway response to ozone in mild asthmatics. Am J Respir Crit Care Med
2001;164(12):2172-6.
427. van den Berge M, Kerstjens HA, Meijer RJ, et al. Corticosteroid-induced
improvement in the PC20 of adenosine monophosphate is more closely associated with
reduction in airway inflammation than improvement in the PC20 of methacholine. Am J
Respir Crit Care Med 2001;164(7):1127-32.
428. Van Den Berge M, Meijer RJ, Kerstjens HA, et al. PC(20) adenosine 5'monophosphate is more closely associated with airway inflammation in asthma than
PC(20) methacholine. Am J Respir Crit Care Med 2001;163(7):1546-50.
429. van der Palen J, Klein JJ, Zielhuis GA, van Herwaarden CL, Seydel ER.
Behavioural effect of self-treatment guidelines in a self-management program for adults
with asthma. Patient Educ Couns 2001;43(2):161-9.
430. Van Der Veen MJ, Jansen HM, Aalberse RC, van der Zee JS. Der p 1 and Der p
2 induce less severe late asthmatic responses than native Dermatophagoides
pteronyssinus extract after a similar early asthmatic response. Clin Exp Allergy
2001;31(5):705-14.
431. van der Woude HJ, Winter TH, Aalbers R. Decreased bronchodilating effect of
salbutamol in relieving methacholine induced moderate to severe bronchoconstriction
during high dose treatment with long acting beta2 agonists. Thorax 2001;56(7):529-35.
432. van der Woude HJ, Aalbers R. Unaltered perception of dyspnoea during
treatment with long-acting beta2-agonists. Eur Respir J 2001;18(2):269-71.
433. van Es SM, Nagelkerke AF, Colland VT, Scholten RJ, Bouter LM. An intervention
programme using the ASE-model aimed at enhancing adherence in adolescents with
asthma. Patient Educ Couns 2001;44(3):193-203.
434. van Rensen EL, Stirling RG, Scheerens J, et al. Evidence for systemic rather
than pulmonary effects of interleukin-5 administration in asthma. Thorax
2001;56(12):935-40.
435. van Veldhoven NH, Vermeer A, Bogaard JM, et al. Children with asthma and
physical exercise: effects of an exercise programme. Clin Rehabil 2001;15(4):360-70.
436. Vancheri C, Mastruzzo C, Armato F, et al. Intranasal heparin reduces eosinophil
recruitment after nasal allergen challenge in patients with allergic rhinitis. J Allergy Clin
Immunol 2001;108(5):703-8.
437. Vercelli D, Baldini M, Stern D, Lohman IC, Halonen M, Martinez F. CD14: a
bridge between innate immunity and adaptive IgE responses. J Endotoxin Res
2001;7(1):45-8.
438. Vercelli D, Baldini M, Martinez F. The monocyte/IgE connection: may
polymorphisms in the CD14 gene teach us about IgE regulation? Int Arch Allergy
Immunol 2001;124(1-3):20-4.
439. Verhoeven GT, Garrelds IM, Hoogsteden HC, Zijlstra FJ. Effects of fluticasone
propionate inhalation on levels of arachidonic acid metabolites in patients with chronic
obstructive pulmonary disease. Mediators Inflamm 2001;10(1):21-6.
440. Vidal C, Dopazo A, Aira MJ. Parietaria pollinosis in an Atlantic area: clinical and
palynological data. J Investig Allergol Clin Immunol 2001;11(2):107-11.
441. Vilsvik J, Ankerst J, Palmqvist M, et al. Protection against cold air and exerciseinduced bronchoconstriction while on regular treatment with Oxis. Respir Med
2001;95(6):484-90.
442. Visser MJ, Postma DS, Arends LR, de Vries TW, Duiverman EJ, Brand PL. Oneyear treatment with different dosing schedules of fluticasone propionate in childhood
asthma. Effects on hyperresponsiveness, lung function, and height. Am J Respir Crit
Care Med 2001;164(11):2073-7.
443. Walker SM, Pajno GB, Lima MT, Wilson DR, Durham SR. Grass pollen
immunotherapy for seasonal rhinitis and asthma: a randomized, controlled trial. J Allergy
Clin Immunol 2001;107(1):87-93.
444. Walsh LJ, Wong CA, Oborne J, et al. Adverse effects of oral corticosteroids in
relation to dose in patients with lung disease. Thorax 2001;56(4):279-84.
445. Warman KL, Silver EJ, Stein RE. Asthma symptoms, morbidity, and
antiinflammatory use in inner-city children. Pediatrics 2001;108(2):277-82.
446. Warner JO. A double-blinded, randomized, placebo-controlled trial of cetirizine in
preventing the onset of asthma in children with atopic dermatitis: 18 months' treatment
and 18 months' posttreatment follow-up. J Allergy Clin Immunol 2001;108(6):929-37.
447. Wensley DC, Silverman M. The quality of home spirometry in school children
with asthma. Thorax 2001;56(3):183-5.
448. Wenzel SE, Morgan K, Griffin R, et al. Improvement in health care utilization and
pulmonary function with fluticasone propionate in patients with steroid-dependent
asthma at a National Asthma Referral Center. J Asthma 2001;38(5):405-12.
449. Williams B, Noonan G, Reiss TF, et al. Long-term asthma control with oral
montelukast and inhaled beclomethasone for adults and children 6 years and older. Clin
Exp Allergy 2001;31(6):845-54.
450. Wilson AM, Dempsey OJ, Sims EJ, Lipworth BJ. A comparison of topical
budesonide and oral montelukast in seasonal allergic rhinitis and asthma. Clin Exp
Allergy 2001;31(4):616-24.
451. Wilson AM, Dempsey OJ, Sims EJ, Lipworth BJ. Evaluation of salmeterol or
montelukast as second-line therapy for asthma not controlled with inhaled
corticosteroids. Chest 2001;119(4):1021-6.
452. Wilson AM, Sims EJ, Orr LC, et al. Effects of topical corticosteroid and combined
mediator blockade on domiciliary and laboratory measurements of nasal function in
seasonal allergic rhinitis. Ann Allergy Asthma Immunol 2001;87(4):344-9.
453. Wilson SJ, Wallin A, Della-Cioppa G, Sandstrom T, Holgate ST. Effects of
budesonide and formoterol on NF-kappaB, adhesion molecules, and cytokines in
asthma. Am J Respir Crit Care Med 2001;164(6):1047-52.
454. Wilson SR, Yamada EG, Sudhakar R, et al. A controlled trial of an environmental
tobacco smoke reduction intervention in low-income children with asthma. Chest
2001;120(5):1709-22.
455. Worth H, Muir JF, Pieters WR. Comparison of hydrofluoroalkanebeclomethasone dipropionate Autohaler with budesonide Turbuhaler in asthma control.
Respiration 2001;68(5):517-26.
456. Yamauchi K, Tanifuji Y, Pan LH, et al. Effects of pranlukast, a leukotriene
receptor antagonist, on airway inflammation in mild asthmatics. J Asthma 2001;38(1):517.
457. Yanase DJ, David-Bajar K. The leukotriene antagonist montelukast as a
therapeutic agent for atopic dermatitis. J Am Acad Dermatol 2001;44(1):89-93.
458. Yoo SH, Park SH, Song JS, et al. Clinical effects of pranlukast, an oral
leukotriene receptor antagonist, in mild-to-moderate asthma: a 4 week randomized
multicentre controlled trial. Respirology 2001;6(1):15-21.
459. Young NL, Foster AM, Parkin PC, et al. Assessing the efficacy of a school-based
asthma education program for children: a pilot study. Can J Public Health 2001;92(1):304.
460. Yuksel H, Coskun S, Polat M, Onag A. Lower arrythmogenic risk of low dose
albuterol plus ipratropium. Indian J Pediatr 2001;68(10):945-9.
461. Zetterstrom O, Buhl R, Mellem H, et al. Improved asthma control with
budesonide/formoterol in a single inhaler, compared with budesonide alone. Eur Respir
J 2001;18(2):262-8.
462. Adams RJ, Fuhlbrigge AL, Finkelstein JA, Weiss ST. Intranasal steroids and the
risk of emergency department visits for asthma. J Allergy Clin Immunol 2002;109(4):63642.
463. Alonso-Llamazares A, Martinez-Cocera C, Dominguez-Ortega J, RobledoEcharren T, Cimarra-Alvarez M, Mesa del Castillo M. Nasal provocation test (NPT) with
aspirin: a sensitive and safe method to diagnose aspirin-induced asthma (AIA). Allergy
2002;57(7):632-5.
464. Alothman GA, Alsaadi MM, Ho BL, et al. Evaluation of bronchial constriction in
children with cystic fibrosis after inhaling two different preparations of tobramycin. Chest
2002;122(3):930-4.
465. Anhoj J, Bisgaard AM, Bisgaard H. Systemic activity of inhaled steroids in 1- to 3year-old children with asthma. Pediatrics 2002;109(3):E40.
466. Baba K, Sakakibara A, Yagi T, Niwa S, Wakayama H, Takagi K. Long-term
observations of the clinical course after step down of corticosteroid inhalation therapy in
adult chronic asthmatics: correlation with serum levels of eosinophil cationic protein.
Respirology 2002;7(3):255-66.
467. Bacci E, Di Franco A, Bartoli ML, et al. Comparison of anti-inflammatory and
clinical effects of beclomethasone dipropionate and salmeterol in moderate asthma. Eur
Respir J 2002;20(1):66-72.
468. Bag R, Bandi V, Fromm RE, Jr., Guntupalli KK. The effect of heliox-driven
bronchodilator aerosol therapy on pulmonary function tests in patients with asthma. J
Asthma 2002;39(7):659-65.
469. Baki A, Orhan F. The effect of loratadine in exercise-induced asthma. Arch Dis
Child 2002;86(1):38-9.
470. Baldwin CM, Long K, Kroesen K, Brooks AJ, Bell IR. A profile of military veterans
in the southwestern United States who use complementary and alternative medicine:
implications for integrated care. Arch Intern Med 2002;162(15):1697-704.
471. Ball DJ, Hirst PH, Newman SP, Sonet B, Streel B, Vanderbist F. Deposition and
pharmacokinetics of budesonide from the Miat Monodose inhaler, a simple dry powder
device. Int J Pharm 2002;245(1-2):123-32.
472. Bartoli ML, Bacci E, Carnevali S, et al. Quality evaluation of samples obtained by
spontaneous or induced sputum: comparison between two methods of processing and
relationship with clinical and functional findings. J Asthma 2002;39(6):479-86.
473. Basomba A, Tabar AI, de Rojas DH, et al. Allergen vaccination with a liposomeencapsulated extract of Dermatophagoides pteronyssinus: a randomized, double-blind,
placebo-controlled trial in asthmatic patients. J Allergy Clin Immunol 2002;109(6):943-8.
474. Bauer CP, Petermann F, Kiosz D, Stachow R. [Long-term effect of indoor
rehabilitation on children and young people with moderate and severe asthma].
Pneumologie 2002;56(8):478-85.
475. Baumgarten C, Geldszus R, Behre U, Peslis N, Trautmann M. Initial treatment of
symptomatic mild to moderate bronchial asthma with the salmeterol/fluticasone
propionate (50/250 microg) combination product (SAS 40023). Eur J Med Res
2002;7(1):1-7.
476. Bensch G, Berger WE, Blokhin BM, et al. One-year efficacy and safety of inhaled
formoterol dry powder in children with persistent asthma. Ann Allergy Asthma Immunol
2002;89(2):180-90.
477. Berger WE, Schenkel EJ, Mansfield LE. Safety and efficacy of desloratadine 5
mg in asthma patients with seasonal allergic rhinitis and nasal congestion. Ann Allergy
Asthma Immunol 2002;89(5):485-91.
478. Berger WE, Ford LB, Mahr T, et al. Efficacy and safety of fluticasone propionate
250 microg administered once daily in patients with persistent asthma treated with or
without inhaled corticosteroids. Ann Allergy Asthma Immunol 2002;89(4):393-9.
479. Bessmertny O, DiGregorio RV, Cohen H, et al. A randomized clinical trial of
nebulized magnesium sulfate in addition to albuterol in the treatment of acute mild-tomoderate asthma exacerbations in adults. Ann Emerg Med 2002;39(6):585-91.
480. Billah MM, Cooper N, Minnicozzi M, et al. Pharmacology of N-(3,5-dichloro-1oxido-4-pyridinyl)-8-methoxy-2-(trifluoromethyl)-5-quino line carboxamide (SCH 351591),
a novel, orally active phosphodiesterase 4 inhibitor. J Pharmacol Exp Ther
2002;302(1):127-37.
481. Bockenhauer SE, Julliard KN, Lo KS, Huang E, Sheth AM. Quantifiable effects of
osteopathic manipulative techniques on patients with chronic asthma. J Am Osteopath
Assoc 2002;102(7):371-5; discussion 5.
482. Bodtger U, Poulsen LK, Jacobi HH, Malling HJ. The safety and efficacy of
subcutaneous birch pollen immunotherapy - a one-year, randomised, double-blind,
placebo-controlled study. Allergy 2002;57(4):297-305.
483. Bonner S, Zimmerman BJ, Evans D, Irigoyen M, Resnick D, Mellins RB. An
individualized intervention to improve asthma management among urban Latino and
African-American families. J Asthma 2002;39(2):167-79.
484. Bousquet J, Ben-Joseph R, Messonnier M, Alemao E, Gould AL. A metaanalysis of the dose-response relationship of inhaled corticosteroids in adolescents and
adults with mild to moderate persistent asthma. Clin Ther 2002;24(1):1-20.
485. Brabson JH, Clifford D, Kerwin E, et al. Efficacy and safety of low-dose
fluticasone propionate compared with zafirlukast in patients with persistent asthma. Am J
Med 2002;113(1):15-21.
486. Bronsky EA, Yegen U, Yeh CM, Larsen LV, Della Cioppa G. Formoterol provides
long-lasting protection against exercise-induced bronchospasm. Ann Allergy Asthma
Immunol 2002;89(4):407-12.
487. Browne GJ, Trieu L, Van Asperen P. Randomized, double-blind, placebocontrolled trial of intravenous salbutamol and nebulized ipratropium bromide in early
management of severe acute asthma in children presenting to an emergency
department. Crit Care Med 2002;30(2):448-53.
488. Brygge T, Heinig JH, Collins P, et al. [Zone therapy and asthma]. Ugeskr Laeger
2002;164(18):2405-10.
489. Buhl R, Soler M, Matz J, et al. Omalizumab provides long-term control in patients
with moderate-to-severe allergic asthma. Eur Respir J 2002;20(1):73-8.
490. Burkhart PV, Dunbar-Jacob JM, Fireman P, Rohay J. Children's adherence to
recommended asthma self-management. Pediatr Nurs 2002;28(4):409-14.
491. Cazzola M, Grella E, Matera MG, Mazzarella G, Marsico SA. Onset of action
following formoterol Turbuhaler and salbutamol pMDI in reversible chronic airway
obstruction. Pulm Pharmacol Ther 2002;15(2):97-102.
492. Celedon JC, Litonjua AA, Ryan L, Platts-Mills T, Weiss ST, Gold DR. Exposure
to cat allergen, maternal history of asthma, and wheezing in first 5 years of life. Lancet
2002;360(9335):781-2.
493. Chalmers GW, Macleod KJ, Little SA, Thomson LJ, McSharry CP, Thomson NC.
Influence of cigarette smoking on inhaled corticosteroid treatment in mild asthma.
Thorax 2002;57(3):226-30.
494. Chernoff RG, Ireys HT, DeVet KA, Kim YJ. A randomized, controlled trial of a
community-based support program for families of children with chronic illness: pediatric
outcomes. Arch Pediatr Adolesc Med 2002;156(6):533-9.
495. Chervinsky P, Nelson HS, Bernstein DI, Berkowitz RA, Siegel SC. Comparison of
mometasone furoate administered by metered dose inhaler with beclomethasone
dipropionate. Int J Clin Pract 2002;56(6):419-25.
496. Chhabra SK, Pandey KK. Comparison of acute bronchodilator effects of inhaled
ipratropium bromide and salbutamol in bronchial asthma. J Asthma 2002;39(5):375-81.
497. Chinn S. Comparing and combining studies of bronchial responsiveness. Thorax
2002;57(5):393-5.
498. Choi IS, Koh YI. Therapeutic effects of BCG vaccination in adult asthmatic
patients: a randomized, controlled trial. Ann Allergy Asthma Immunol 2002;88(6):584-91.
499. Chuchalin AG, Ovcharenko SI, Goriachkina LA, Sidorenko IV, Tsoi AN. The
safety and efficacy of formoterol (Oxis) turbuhaler plus budesonide (Pulmicort)
turbuhaler in mild to moderate asthma: a comparison with budesonide Turbuhaler alone
and current non-corticosteroid therapy in Russia. Int J Clin Pract 2002;56(1):15-20.
500. Couturaud F, Proust A, Frachon I, et al. Education and self-management: a oneyear randomized trial in stable adult asthmatic patients. J Asthma 2002;39(6):493-500.
501. Creticos PS, Adams WP, Petty BG, et al. A methacholine challenge doseresponse study for development of a pharmacodynamic bioequivalence methodology for
albuterol metered- dose inhalers. J Allergy Clin Immunol 2002;110(5):713-20.
502. Crystal-Peters J, Neslusan C, Crown WH, Torres A. Treating allergic rhinitis in
patients with comorbid asthma: the risk of asthma-related hospitalizations and
emergency department visits. J Allergy Clin Immunol 2002;109(1):57-62.
503. Currie GP, Fowler SJ, Wilson AM, Sims EJ, Orr LC, Lipworth BJ. Airway and
systemic effects of hydrofluoroalkane fluticasone and beclomethasone in patients with
asthma. Thorax 2002;57(10):865-8.
504. Currie GP, Lipworth BJ. Bronchoprotective effects of leukotriene receptor
antagonists in asthma: a meta-analysis. Chest 2002;122(1):146-50.
505. Dahlen B, Roquet A, Inman MD, et al. Influence of zafirlukast and loratadine on
exercise-induced bronchoconstriction. J Allergy Clin Immunol 2002;109(5):789-93.
506. Dahlen SE, Malmstrom K, Nizankowska E, et al. Improvement of aspirinintolerant asthma by montelukast, a leukotriene antagonist: a randomized, double-blind,
placebo-controlled trial. Am J Respir Crit Care Med 2002;165(1):9-14.
507. de Kluijver J, Evertse CE, Schrumpf JA, et al. Asymptomatic worsening of airway
inflammation during low-dose allergen exposure in asthma: protection by inhaled
steroids. Am J Respir Crit Care Med 2002;166(3):294-300.
508. de Koning JP, van der Mark TW, Coenegracht PM, Tromp TF, Frijlink HW. Effect
of an external resistance to airflow on the inspiratory flow curve. Int J Pharm 2002;234(12):257-66.
509. Dempsey OJ, Kennedy G, Lipworth BJ. Comparative efficacy and antiinflammatory profile of once-daily therapy with leukotriene antagonist or low-dose
inhaled corticosteroid in patients with mild persistent asthma. J Allergy Clin Immunol
2002;109(1):68-74.
510. Dempsey OJ, Fowler SJ, Wilson A, Kennedy G, Lipworth BJ. Effects of adding
either a leukotriene receptor antagonist or low-dose theophylline to a low or medium
dose of inhaled corticosteroid in patients with persistent asthma. Chest 2002;122(1):1519.
511. Di Lorenzo G, Pacor ML, Morici G, et al. Measurement of inflammatory mediators
of eosinophils and lymphocytes in blood in acute asthma: serum levels of ECP influence
the bronchodilator response. Int Arch Allergy Immunol 2002;127(4):308-15.
512. Dicpinigaitis PV, Dobkin JB, Reichel J. Antitussive effect of the leukotriene
receptor antagonist zafirlukast in subjects with cough-variant asthma. J Asthma
2002;39(4):291-7.
513. Douma WR, Kerstjens HA, de Gooijer A, Overbeek SE, Koeter GH, Postma DS.
Initial improvements in lung function and bronchial hyperresponsiveness are maintained
during 5 years of treatment with inhaled beclomethasone dipropionate and terbutaline.
Chest 2002;121(1):151-7.
514. Ducharme FM. Anti-leukotrienes as add-on therapy to inhaled glucocorticoids in
patients with asthma: systematic review of current evidence. BMJ 2002;324(7353):1545.
515. D'Urzo A, Jugovic P. Chronic cough. Three most common causes. Can Fam
Physician 2002;48:1311-6.
516. Dyer CA, Singh SJ, Stockley RA, Sinclair AJ, Hill SL. The incremental shuttle
walking test in elderly people with chronic airflow limitation. Thorax 2002;57(1):34-8.
517. Eagan TM, Gulsvik A, Eide GE, Bakke PS. Occupational airborne exposure and
the incidence of respiratory symptoms and asthma. Am J Respir Crit Care Med
2002;166(7):933-8.
518. Eccles M, Rousseau N, Freemantle N. Updating evidence-based clinical
guidelines. J Health Serv Res Policy 2002;7(2):98-103.
519. Eccles M, McColl E, Steen N, et al. Effect of computerised evidence based
guidelines on management of asthma and angina in adults in primary care: cluster
randomised controlled trial. Bmj 2002;325(7370):941.
520. Edmonds ML, Camargo CA, Jr., Brenner BE, Rowe BH. Replacement of oral
corticosteroids with inhaled corticosteroids in the treatment of acute asthma following
emergency department discharge: a meta-analysis. Chest 2002;121(6):1798-805.
521. Edmonds ML, Camargo CA, Jr., Pollack CV, Jr., Rowe BH. The effectiveness of
inhaled corticosteroids in the emergency department treatment of acute asthma: a metaanalysis. Ann Emerg Med 2002;40(2):145-54.
522. Ekici A, Ekici M, Erdemoglu AK. Effect of azithromycin on the severity of
bronchial hyperresponsiveness in patients with mild asthma. J Asthma 2002;39(2):1815.
523. Ekiel A, Friedek D, Szulakowski P, Romanik M, Rogala-Zawada D, Wilk I.
[Incidence of selected bacterial pathogens of the respiratory tract in patients with
bronchial asthma]. Wiad Lek 2002;55(1-2):11-8.
524. Emel'ianov AV, Trendeleva TE, Krasnoshchekova OI, Shubin SA, Katysheva NS.
[Efficacy and safety of high doses of beclomethasone dipropionate in patients with
bronchial asthma]. Ter Arkh 2002;74(3):29-31.
525. Everden P, Lloyd A, Hutchinson J, Plumb J. Cost-effectiveness of eformoterol
Turbohaler versus salmeterol Accuhaler in children with symptomatic asthma. Respir
Med 2002;96(4):250-8.
526. Faul JL, Demers EA, Burke CM, Poulter LW. Alterations in airway inflammation
and lung function during corticosteroid therapy for atopic asthma. Chest
2002;121(5):1414-20.
527. Forastiere F, Lo Presti E, Agabiti N, Rapiti E, Perucci CA. [Health impact of
exposure to environmental tobacco smoke in Italy]. Epidemiol Prev 2002;26(1):18-29.
528. Fowler SJ, Currie GP, Lipworth BJ. Step-down therapy with low-dose fluticasonesalmeterol combination or medium-dose hydrofluoroalkane 134a-beclomethasone alone.
J Allergy Clin Immunol 2002;109(6):929-35.
529. Fowler SJ, Orr LC, Sims EJ, et al. Therapeutic ratio of hydrofluoroalkane and
chlorofluorocarbon formulations of fluticasone propionate. Chest 2002;122(2):618-23.
530. Fretheim A, Bjorndal A, Oxman AD, et al. [Which antihypertensive drugs should
be used in the primary prevention of cardiovascular disease?]. Tidsskr Nor Laegeforen
2002;122(23):2283-6.
531. Frew AJ, Langley SJ, Perrin V, Hertog MG. Effects of 4-week treatment with lowdose budesonide (100 micrograms BID) from a novel inhaler Airmax and from a
conventional inhaler on bronchial hyper-responsiveness, lung function and symptoms in
patients with mild asthma. Respir Med 2002;96(7):542-7.
532. Gauvreau GM, Inman MD, Kelly M, Watson RM, Dorman SC, O'Byrne PM.
Increased levels of airway neutrophils reduce the inhibitory effects of inhaled
glucocorticosteroids on allergen-induced airway eosinophils. Can Respir J 2002;9(1):2632.
533. Gazdik F, Kadrabova J, Gazdikova K. Decreased consumption of corticosteroids
after selenium supplementation in corticoid-dependent asthmatics. Bratisl Lek Listy
2002;103(1):22-5.
534. Gazdik F, Horvathova M, Gazdikova K, Jahnova E. The influence of selenium
supplementation on the immunity of corticoid-dependent asthmatics. Bratisl Lek Listy
2002;103(1):17-21.
535. Gel'tser BI, Kochetkova EA. [Parameters of bone tissue density in patients with
bronchial asthma]. Ter Arkh 2002;74(1):64-7.
536. Giner J, Macian V, Hernandez C. [Multicenter prospective study of respiratory
patient education and instruction in the use of inhalers (EDEN study)]. Arch
Bronconeumol 2002;38(7):300-5.
537. Gizycki MJ, Hattotuwa KL, Barnes N, Jeffery PK. Effects of fluticasone
propionate on inflammatory cells in COPD: an ultrastructural examination of
endobronchial biopsy tissue. Thorax 2002;57(9):799-803.
538. Goldberg S, Einot T, Algur N, et al. Adrenal suppression in asthmatic children
receiving low-dose inhaled budesonide: comparison between dry powder inhaler and
pressurized metered-dose inhaler attached to a spacer. Ann Allergy Asthma Immunol
2002;89(6):566-71.
539. Green RH, Brightling CE, McKenna S, et al. Asthma exacerbations and sputum
eosinophil counts: a randomised controlled trial. Lancet 2002;360(9347):1715-21.
540. Green RH, Brightling CE, Woltmann G, Parker D, Wardlaw AJ, Pavord ID.
Analysis of induced sputum in adults with asthma: identification of subgroup with isolated
sputum neutrophilia and poor response to inhaled corticosteroids. Thorax
2002;57(10):875-9.
541. Groeben H, Schafer B, Pavlakovic G, Silvanus MT, Peters J. Lung function under
high thoracic segmental epidural anesthesia with ropivacaine or bupivacaine in patients
with severe obstructive pulmonary disease undergoing breast surgery. Anesthesiology
2002;96(3):536-41.
542. Groeben H, Schlicht M, Stieglitz S, Pavlakovic G, Peters J. Both local anesthetics
and salbutamol pretreatment affect reflex bronchoconstriction in volunteers with asthma
undergoing awake fiberoptic intubation. Anesthesiology 2002;97(6):1445-50.
543. Grover N, Kumaraiah V, Prasadrao PS, D'Souza G. Cognitive behavioural
intervention in bronchial asthma. J Assoc Physicians India 2002;50:896-900.
544. Gruber W, Eber E, Malle-Scheid D, et al. Laser acupuncture in children and
adolescents with exercise induced asthma. Thorax 2002;57(3):222-5.
545. Guendelman S, Meade K, Benson M, Chen YQ, Samuels S. Improving asthma
outcomes and self-management behaviors of inner-city children: a randomized trial of
the Health Buddy interactive device and an asthma diary. Arch Pediatr Adolesc Med
2002;156(2):114-20.
546. Gustafsson P, Kallman S, Whitehead PJ. Clinical equivalence between
salbutamol hydrofluoroalkane pMDI and salbutamol Turbuhaler at the same cumulative
microgram doses in paediatric patients. Respir Med 2002;96(11):957-9.
547. Hadjikoumi I, Loader P, Bracken M, Milner AD. Bronchodilator therapy and
hyperactivity in preschool children. Arch Dis Child 2002;86(3):202-3.
548. Hancox RJ, Subbarao P, Kamada D, Watson RM, Hargreave FE, Inman MD.
Beta2-agonist tolerance and exercise-induced bronchospasm. Am J Respir Crit Care
Med 2002;165(8):1068-70.
549. Hattotuwa KL, Gizycki MJ, Ansari TW, Jeffery PK, Barnes NC. The effects of
inhaled fluticasone on airway inflammation in chronic obstructive pulmonary disease: a
double-blind, placebo-controlled biopsy study. Am J Respir Crit Care Med
2002;165(12):1592-6.
550. Hawksworth RJ, Sykes AP, Faris M, Mant T, Lee TH. Albuterol HFA is as
effective as albuterol CFC in preventing exercise-induced bronchoconstriction. Ann
Allergy Asthma Immunol 2002;88(5):473-7.
551. Helin T, Haahtela S, Haahtela T. No effect of oral treatment with an intestinal
bacterial strain, Lactobacillus rhamnosus (ATCC 53103), on birch-pollen allergy: a
placebo-controlled double-blind study. Allergy 2002;57(3):243-6.
552. Hoogenveen R, Westert G, Dijkgraaf M, Schellevis F, de Bakker D. Disease
prevalence estimations based on contact registrations in general practice. Stat Med
2002;21(15):2271-85.
553. Hubbard RB, Smith CJ, Smeeth L, Harrison TW, Tattersfield AE. Inhaled
corticosteroids and hip fracture: a population-based case-control study. Am J Respir Crit
Care Med 2002;166(12 Pt 1):1563-6.
554. Huntley A, White AR, Ernst E. Relaxation therapies for asthma: a systematic
review. Thorax 2002;57(2):127-31.
555. Irani AM, Cruz-Rivera M, Fitzpatrick S, Hoag J, Smith JA. Effects of budesonide
inhalation suspension on hypothalamic-pituitary-adrenal-axis function in infants and
young children with persistent asthma. Ann Allergy Asthma Immunol 2002;88(3):306-12.
556. Isaksson M, Bruze M. Allergic contact dermatitis in response to budesonide
reactivated by inhalation of the allergen. J Am Acad Dermatol 2002;46(6):880-5.
557. Israel E, Chervinsky PS, Friedman B, et al. Effects of montelukast and
beclomethasone on airway function and asthma control. J Allergy Clin Immunol
2002;110(6):847-54.
558. Ito K, Lim S, Caramori G, et al. A molecular mechanism of action of theophylline:
Induction of histone deacetylase activity to decrease inflammatory gene expression.
Proc Natl Acad Sci U S A 2002;99(13):8921-6.
559. Jahnova E, Horvathova M, Gazdik F, Weissova S. Effects of selenium
supplementation on expression of adhesion molecules in corticoid-dependent
asthmatics. Bratisl Lek Listy 2002;103(1):12-6.
560. Janssen R, Weda M, Ekkelenkamp MB, Lammers JW, Zanen P. Metal versus
plastic spacers: an in vitro and in vivo comparison. Int J Pharm 2002;245(1-2):93-8.
561. Jones A, Fay JK, Burr M, Stone M, Hood K, Roberts G. Inhaled corticosteroid
effects on bone metabolism in asthma and mild chronic obstructive pulmonary disease.
Cochrane Database Syst Rev 2002(1):CD003537.
562. Jones AM, Munavvar M, Vail A, et al. Prospective, placebo-controlled trial of 5 vs
10 days of oral prednisolone in acute adult asthma. Respir Med 2002;96(11):950-4.
563. Jones PW. Applying evidence and theory to guide clinical decision making-implications for asthma management. Respir Med 2002;96(8):567-71.
564. Jung A, Kalicki B, Zuber J, Dadas E, Straz-Zebrowska E. [Spirometry evaluation
of montelukast treatment in children with bronchial asthma]. Pol Merkuriusz Lek
2002;12(68):92-4.
565. Juniper EF, Price DB, Stampone PA, Creemers JP, Mol SJ, Fireman P. Clinically
important improvements in asthma-specific quality of life, but no difference in
conventional clinical indexes in patients changed from conventional beclomethasone
dipropionate to approximately half the dose of extrafine beclomethasone dipropionate.
Chest 2002;121(6):1824-32.
566. Kamio Y, Nanbu Y, Futamata H, Fujita S, Kobayashi T, Fujimura M. [Comparison
of reproducibility to measure cough sensitivity between our original and astograph
methods]. Rinsho Byori 2002;50(4):410-4.
567. Kanazawa H, Shiraishi S, Hirata K, Yoshikawa J. Decreased peroxynitrite
inhibitory activity in induced sputum in patients with bronchial asthma. Thorax
2002;57(6):509-12.
568. Kanter LJ, Siegel CJ, Snyder CF, Pelletier EM, Buchner DA, Goss TF. Impact of
respiratory symptoms on health-related quality of life and medical resource utilization of
patients treated by allergy specialists and primary care providers. Ann Allergy Asthma
Immunol 2002;89(2):139-47.
569. Kawano T, Matsuse H, Obase Y, et al. Hypogammaglobulinemia in steroiddependent asthmatics correlates with the daily dose of oral prednisolone. Int Arch
Allergy Immunol 2002;128(3):240-3.
570. Kayani S, Shannon DC. Adverse behavioral effects of treatment for acute
exacerbation of asthma in children: a comparison of two doses of oral steroids. Chest
2002;122(2):624-8.
571. Kaye P, O'Sullivan I. The role of magnesium in the emergency department.
Emerg Med J 2002;19(4):288-91.
572. Ketchell RI, Jensen MW, Lumley P, Wright AM, Allenby MI, O'Connor B J. Rapid
effect of inhaled fluticasone propionate on airway responsiveness to adenosine 5'monophosphate in mild asthma. J Allergy Clin Immunol 2002;110(4):603-6.
573. Ketchell RI, D'Amato M, Jensen MW, O'Connor BJ. Contrasting effects of
allergen challenge on airway responsiveness to cysteinyl leukotriene D(4) and
methacholine in mild asthma. Thorax 2002;57(7):575-80.
574. Kharitonov SA, Donnelly LE, Montuschi P, Corradi M, Collins JV, Barnes PJ.
Dose-dependent onset and cessation of action of inhaled budesonide on exhaled nitric
oxide and symptoms in mild asthma. Thorax 2002;57(10):889-96.
575. Kishida M, Suzuki I, Kabayama H, et al. Mouthpiece versus facemask for delivery
of nebulized salbutamol in exacerbated childhood asthma. J Asthma 2002;39(4):337-9.
576. Kochetkova EA, Gel'tser BI. [Alphacalcidol in the treatment of osteopenic
syndrome in patients with bronchial asthma]. Ter Arkh 2002;74(3):32-5.
577. Kopp MV, Brauburger J, Riedinger F, et al. The effect of anti-IgE treatment on in
vitro leukotriene release in children with seasonal allergic rhinitis. J Allergy Clin Immunol
2002;110(5):728-35.
578. Kraft M, Cassell GH, Pak J, Martin RJ. Mycoplasma pneumoniae and Chlamydia
pneumoniae in asthma: effect of clarithromycin. Chest 2002;121(6):1782-8.
579. Kramer MS, Kakuma R. Optimal duration of exclusive breastfeeding. Cochrane
Database Syst Rev 2002(1):CD003517.
580. Kress JP, Noth I, Gehlbach BK, et al. The utility of albuterol nebulized with heliox
during acute asthma exacerbations. Am J Respir Crit Care Med 2002;165(9):1317-21.
581. Krieger JK, Takaro TK, Allen C, et al. The Seattle-King County healthy homes
project: implementation of a comprehensive approach to improving indoor environmental
quality for low-income children with asthma. Environ Health Perspect 2002;110 Suppl
2:311-22.
582. Landyshev Iu S, Avdeeva NV, Goborov ND, Krasavina NP, Tikhonova GA,
Tkacheva SI. [Efficacy of low intensity laser irradiation and sodium nedocromil in the
complex treatment of patients with bronchial asthma]. Ter Arkh 2002;74(3):25-8.
583. Langley SJ, Sykes AP, Batty EP, Masterson CM, Woodcock A. A comparison of
the efficacy and tolerability of single doses of HFA 134a albuterol and CFC albuterol in
mild-to-moderate asthmatic patients. Ann Allergy Asthma Immunol 2002;88(5):488-93.
584. Langley SJ, Holden J, Derham A, Hedgeland P, Sharma RK, Woodcock A.
Fluticasone propionate via the Diskhaler or hydrofluoroalkane-134a metered-dose
inhaler on methacholine-induced airway hyperresponsiveness. Chest 2002;122(3):80611.
585. Lazenby JP, Guzzo MR, Harding SM, Patterson PE, Johnson LF, Bradley LA.
Oral corticosteroids increase esophageal acid contact times in patients with stable
asthma. Chest 2002;121(2):625-34.
586. Lee-Wong M, Dayrit FM, Kohli AR, Acquah S, Mayo PH. Comparison of highdose inhaled flunisolide to systemic corticosteroids in severe adult asthma. Chest
2002;122(4):1208-13.
587. Lefevre F, Piper M, Weiss K, Mark D, Clark N, Aronson N. Do written action
plans improve patient outcomes in asthma? An evidence-based analysis. J Fam Pract
2002;51(10):842-8.
588. Leflein JG, Szefler SJ, Murphy KR, et al. Nebulized budesonide inhalation
suspension compared with cromolyn sodium nebulizer solution for asthma in young
children: results of a randomized outcomes trial. Pediatrics 2002;109(5):866-72.
589. Leigh R, Vethanayagam D, Yoshida M, et al. Effects of montelukast and
budesonide on airway responses and airway inflammation in asthma. Am J Respir Crit
Care Med 2002;166(9):1212-7.
590. Lesko SM, Louik C, Vezina RM, Mitchell AA. Asthma morbidity after the shortterm use of ibuprofen in children. Pediatrics 2002;109(2):E20.
591. Leuppi JD, Downie SR, Salome CM, Jenkins CR, Woolcock AJ. A single high
dose of inhaled corticosteroids: a possible treatment of asthma exacerbations. Swiss
Med Wkly 2002;132(1-2):7-11.
592. Leverkoehne I, Gruber AD. The murine mCLCA3 (alias gob-5) protein is located
in the mucin granule membranes of intestinal, respiratory, and uterine goblet cells. J
Histochem Cytochem 2002;50(6):829-38.
593. Lewith GT, Watkins AD, Hyland ME, et al. Use of ultramolecular potencies of
allergen to treat asthmatic people allergic to house dust mite: double blind randomised
controlled clinical trial. Bmj 2002;324(7336):520.
594. Lin YZ, Huang FY. A comparison of terbutaline and fenoterol unit dose vials in
treating children with acute asthmatic attacks. Acta Paediatr Taiwan 2002;43(4):187-92.
595. Liu LY, Coe CL, Swenson CA, Kelly EA, Kita H, Busse WW. School
examinations enhance airway inflammation to antigen challenge. Am J Respir Crit Care
Med 2002;165(8):1062-7.
596. Lowhagen O, Wever AM, Lusuardi M, et al. The inflammatory marker serum
eosinophil cationic protein (ECP) compared with PEF as a tool to decide inhaled
corticosteroid dose in asthmatic patients. Respir Med 2002;96(2):95-101.
597. Lukacs SL, France EK, Baron AE, Crane LA. Effectiveness of an asthma
management program for pediatric members of a large health maintenance organization.
Arch Pediatr Adolesc Med 2002;156(9):872-6.
598. Maltais F, Ostinelli J, Bourbeau J, et al. Comparison of nebulized budesonide
and oral prednisolone with placebo in the treatment of acute exacerbations of chronic
obstructive pulmonary disease: a randomized controlled trial. Am J Respir Crit Care Med
2002;165(5):698-703.
599. Manocha R, Marks GB, Kenchington P, Peters D, Salome CM. Sahaja yoga in
the management of moderate to severe asthma: a randomised controlled trial. Thorax
2002;57(2):110-5.
600. Marabini A, Brugnami G, Curradi F, et al. Short-term effectiveness of an asthma
educational program: results of a randomized controlled trial. Respir Med
2002;96(12):993-8.
601. Mathison DA, Koziol JA. Marginal utility of montelukast for persistent asthma.
Chest 2002;121(2):334-7.
602. McDonald E, Cook D, Newman T, Griffith L, Cox G, Guyatt G. Effect of air
filtration systems on asthma: a systematic review of randomized trials. Chest
2002;122(5):1535-42.
603. McMullen AH, Yoos HL, Kitzman H. Peak flow meters in childhood asthma:
parent report of use and perceived usefulness. J Pediatr Health Care 2002;16(2):67-72.
604. Medvedeva IV, Lapik SV, Gur'eva SA, Savina IA. [Clinical and biochemical
aspects of flixotide administration in patients with moderate bronchial asthma]. Ter Arkh
2002;74(3):21-5.
605. Meltzer EO, Lockey RF, Friedman BF, et al. Efficacy and safety of low-dose
fluticasone propionate compared with montelukast for maintenance treatment of
persistent asthma. Mayo Clin Proc 2002;77(5):437-45.
606. Metzger WJ, Hampel FC, Jr., Sugar M. Once-daily budesonide inhalation powder
(Pulmicort Turbuhaler) is effective and safe in adults previously treated with inhaled
corticosteroids. J Asthma 2002;39(1):65-75.
607. Meyer U. From khellin to sodium cromoglycate--a tribute to the work of Dr. R. E.
C. Altounyan (1922-1987). Pharmazie 2002;57(1):62-9.
608. Mihrshahi S, Marks G, Vanlaar C, Tovey E, Peat J. Predictors of high house dust
mite allergen concentrations in residential homes in Sydney. Allergy 2002;57(2):137-42.
609. Miller FG, Shorr AF. Ethical assessment of industry-sponsored clinical trials: a
case analysis. Chest 2002;121(4):1337-42.
610. Minoguchi K, Kohno Y, Minoguchi H, et al. Reduction of eosinophilic
inflammation in the airways of patients with asthma using montelukast. Chest
2002;121(3):732-8.
611. Mintz S, Alexander M, Li JH, Mayer PV. Once-daily administration of budesonide
Turbuhaler was as effective as twice-daily treatment in patients with mild to moderate
persistent asthma. J Asthma 2002;39(3):203-10.
612. Moira CY, Ferguson A, Dimich-Ward H, Watson W, Manfreda J, Becker A.
Effectiveness of and compliance to intervention measures in reducing house dust and
cat allergen levels. Ann Allergy Asthma Immunol 2002;88(1):52-8.
613. Moller C, Dreborg S, Ferdousi HA, et al. Pollen immunotherapy reduces the
development of asthma in children with seasonal rhinoconjunctivitis (the PAT-study). J
Allergy Clin Immunol 2002;109(2):251-6.
614. Moniuszko T, Rutkowski R, Tatarczuk-Krawiel A, Stasiak-Barmuta A, Siergiejko
Z. [The role of monocytes stimulated with LPS on CD69 expression in T lymphocytes of
patients with non-atopic asthma]. Pol Merkuriusz Lek 2002;12(69):181-4.
615. Morris MJ, Grbach VX, Deal LE, Boyd SY, Morgan JA, Johnson JE. Evaluation of
exertional dyspnea in the active duty patient: the diagnostic approach and the utility of
clinical testing. Mil Med 2002;167(4):281-8.
616. Narang I, Ersu R, Wilson NM, Bush A. Nitric oxide in chronic airway inflammation
in children: diagnostic use and pathophysiological significance. Thorax 2002;57(7):5869.
617. Nerbrink OL, Lindstrom M, Meurling L, Svartengren M. Inhalation and deposition
of nebulized sodium cromoglycate in two different particle size distributions in children
with asthma. Pediatr Pulmonol 2002;34(5):351-60.
618. Nightingale JA, Rogers DF, Barnes PJ. Comparison of the effects of salmeterol
and formoterol in patients with severe asthma. Chest 2002;121(5):1401-6.
619. Numata Y, Bourbeau J, Ernst P, Duquette G, Schwartzman K. Teaching time for
metered-dose inhalers in the emergency setting. Chest 2002;122(2):498-504.
620. O'Callaghan C, Everard ML, Bush A, et al. Salbutamol dry powder inhaler:
efficacy, tolerability, and acceptability study. Pediatr Pulmonol 2002;33(3):189-93.
621. Oldfield WL, Larche M, Kay AB. Effect of T-cell peptides derived from Fel d 1 on
allergic reactions and cytokine production in patients sensitive to cats: a randomised
controlled trial. Lancet 2002;360(9326):47-53.
622. Ortiz G, Menendez R. The effects of inhaled albuterol and salmeterol in 2- to 5year-old asthmatic children as measured by impulse oscillometry. J Asthma
2002;39(6):531-6.
623. Osman LM, Calder C, Godden DJ, et al. A randomised trial of self-management
planning for adult patients admitted to hospital with acute asthma. Thorax
2002;57(10):869-74.
624. Pachter LM, Weller SC, Baer RD, et al. Variation in asthma beliefs and practices
among mainland Puerto Ricans, Mexican-Americans, Mexicans, and Guatemalans. J
Asthma 2002;39(2):119-34.
625. Paniagua MJ, Bosque M, Asensio O, Larramona H, Marco MT. [Immunotherapy
with acarus extract in children under the age of 5 years]. Allergol Immunopathol (Madr)
2002;30(1):20-4.
626. Passowicz-Muszynska E, Jankowska R, Krasnowska M. [The effect of inhaled
low molecular weight heparin on cell composition in bronchoalveolar lavage fluid and
serum levels of soluble receptor IL-2 in bronchial asthma patients]. Pol Merkuriusz Lek
2002;12(69):218-20.
627. Patriarca G, Nucera E, Pollastrini E, et al. Sublingual desensitization: a new
approach to latex allergy problem. Anesth Analg 2002;95(4):956-60, table of contents.
628. Pearlman DS, White MV, Lieberman AK, et al. Fluticasone propionate/salmeterol
combination compared with montelukast for the treatment of persistent asthma. Ann
Allergy Asthma Immunol 2002;88(2):227-35.
629. Pedersen S, Warner J, Wahn U, et al. Growth, systemic safety, and efficacy
during 1 year of asthma treatment with different beclomethasone dipropionate
formulations: an open-label, randomized comparison of extrafine and conventional
aerosols in children. Pediatrics 2002;109(6):e92.
630. Perneger TV, Sudre P, Muntner P, et al. Effect of patient education on selfmanagement skills and health status in patients with asthma: a randomized trial. Am J
Med 2002;113(1):7-14.
631. Peroni DG, Piacentini GL, Pietrobelli A, et al. The combination of single-dose
montelukast and loratadine on exercise-induced bronchospasm in children. Eur Respir J
2002;20(1):104-7.
632. Pfutzner A, Mann AE, Steiner SS. Technosphere/Insulin--a new approach for
effective delivery of human insulin via the pulmonary route. Diabetes Technol Ther
2002;4(5):589-94.
633. Phipatanakul W, Nowak-Wegrzyn A, Eggleston PA, et al. The efficacy of
montelukast in the treatment of cat allergen-induced asthma in children. J Allergy Clin
Immunol 2002;109(5):794-9.
634. Piacentini GL, Bodini A, Peroni DG, Miraglia del Giudice M, Jr., Costella S, Boner
AL. Reduction in exhaled nitric oxide immediately after methacholine challenge in
asthmatic children. Thorax 2002;57(9):771-3.
635. Pifferi M, Baldini G, Marrazzini G, et al. Benefits of immunotherapy with a
standardized Dermatophagoides pteronyssinus extract in asthmatic children: a threeyear prospective study. Allergy 2002;57(9):785-90.
636. Price MJ, Briggs AH. Development of an economic model to assess the cost
effectiveness of asthma management strategies. Pharmacoeconomics 2002;20(3):18394.
637. Price D, Dutchman D, Mawson A, Bodalia B, Duggan S, Todd P. Early asthma
control and maintenance with eformoterol following reduction of inhaled corticosteroid
dose. Thorax 2002;57(9):791-8.
638. Price J, Lenney W, Duncan C, et al. HPA-axis effects of nebulised fluticasone
propionate compared with oral prednisolone in childhood asthma. Respir Med
2002;96(8):625-31.
639. Prieto L, Gutierrez V, Torres V, Uixera S, Marin J. Effect of salmeterol on
seasonal changes in airway responsiveness and exhaled nitric oxide in pollen-sensitive
asthmatic subjects. Chest 2002;122(3):798-805.
640. Prosperini G, Rajakulasingam K, Cacciola RR, et al. Changes in sputum counts
and airway hyperresponsiveness after budesonide: monitoring anti-inflammatory
response on the basis of surrogate markers of airway inflammation. J Allergy Clin
Immunol 2002;110(6):855-61.
641. Punin AA, Bogachev RS, Zubkov SK, Kozyrev OA, Khokhlova Iu A.
[Cardiovascular and metabolic effects in nebulizer therapy of bronchial asthma]. Klin
Med (Mosk) 2002;80(1):40-3.
642. Raivio T, Palvimo JJ, Kannisto S, Voutilainen R, Janne OA. Transactivation
assay for determination of glucocorticoid bioactivity in human serum. J Clin Endocrinol
Metab 2002;87(8):3740-4.
643. Rajkumar, Vatsa HK, Gaur SN. Comparative evaluation of market spacer and
home made spacer in the management of bronchial asthma. J Assoc Physicians India
2002;50:397-9.
644. Redding G, Walker RE, Hessel C, et al. Safety and tolerability of cold-adapted
influenza virus vaccine in children and adolescents with asthma. Pediatr Infect Dis J
2002;21(1):44-8.
645. Remes ST, Pekkanen J, Remes K, Salonen RO, Korppi M. In search of
childhood asthma: questionnaire, tests of bronchial hyperresponsiveness, and clinical
evaluation. Thorax 2002;57(2):120-6.
646. Renz H, mutius E, Illi S, Wolkers F, Hirsch T, Weiland SK. T(H)1/T(H)2 immune
response profiles differ between atopic children in eastern and western Germany. J
Allergy Clin Immunol 2002;109(2):338-42.
647. Riffelmann FW, Droste G, Lauter H, Kohler D. [Influence of montelukast on
inhalational bronchial allergen provocation]. Pneumologie 2002;56(8):493-7.
648. Rijssenbeek-Nouwens LH, Oosting AJ, De Monchy JG, Bregman I, Postma DS,
De Bruin-Weller MS. The effect of anti-allergic mattress encasings on house dust miteinduced early- and late-airway reactions in asthmatic patients. A double-blind, placebocontrolled study. Clin Exp Allergy 2002;32(1):117-25.
649. Rijssenbeek-Nouwens LH, Oosting AJ, de Bruin-Weller MS, Bregman I, de
Monchy JG, Postma DS. Clinical evaluation of the effect of anti-allergic mattress covers
in patients with moderate to severe asthma and house dust mite allergy: a randomised
double blind placebo controlled study. Thorax 2002;57(9):784-90.
650. Ringdal N, Chuchalin A, Chovan L, Tudoric N, Maggi E, Whitehead PJ.
Evaluation of different inhaled combination therapies (EDICT): a randomised, doubleblind comparison of Seretide (50/250 microg bd Diskus vs. formoterol (12 microg bd)
and budesonide (800 microg bd) given concurrently (both via Turbuhaler) in patients with
moderate-to-severe asthma. Respir Med 2002;96(11):851-61.
651. Ringsberg KC, Lepp M, Finnstrom B. Experiences by patients with asthma-like
symptoms of a problem-based learning health education programme. Fam Pract
2002;19(3):290-3.
652. Rinne J, Simola M, Malmberg H, Haahtela T. Early treatment of perennial rhinitis
with budesonide or cetirizine and its effect on long-term outcome. J Allergy Clin Immunol
2002;109(3):426-32.
653. Rodrigo GJ, Rodrigo C. The role of anticholinergics in acute asthma treatment:
an evidence-based evaluation. Chest 2002;121(6):1977-87.
654. Rodrigo GJ, Rodrigo C. Continuous vs intermittent beta-agonists in the treatment
of acute adult asthma: a systematic review with meta-analysis. Chest 2002;122(1):1605.
655. Rodriguez MA, Winkleby MA, Ahn D, Sundquist J, Kraemer HC. Identification of
population subgroups of children and adolescents with high asthma prevalence: findings
from the Third National Health and Nutrition Examination Survey. Arch Pediatr Adolesc
Med 2002;156(3):269-75.
656. Romieu I, Sienra-Monge JJ, Ramirez-Aguilar M, et al. Antioxidant
supplementation and lung functions among children with asthma exposed to high levels
of air pollutants. Am J Respir Crit Care Med 2002;166(5):703-9.
657. Rorke S, Jennison S, Jeffs JA, Sampson AP, Arshad H, Holgate ST. Role of
cysteinyl leukotrienes in adenosine 5'-monophosphate induced bronchoconstriction in
asthma. Thorax 2002;57(4):323-7.
658. Rose JS, Panacek EA, Miller P. Prospective randomized trial of heliox-driven
continuous nebulizers in the treatment of asthma in the emergency department. J Emerg
Med 2002;22(2):133-7.
659. Rosenhall L, Heinig JH, Lindqvist A, Leegaard J, Stahl E, Bergqvist PB.
Budesonide/formoterol (Symbicort) is well tolerated and effective in patients with
moderate persistent asthma. Int J Clin Pract 2002;56(6):427-33.
660. Ruoff G. Effects of flow sheet implementation on physician performance in the
management of asthmatic patients. Fam Med 2002;34(7):514-7.
661. Rutkowski R, Moniuszko T, Stasiak-Barmuta A, Rutkowska-Rogacz D, Siergiejko
Z. [The effect of inactivation of co-stimulated particles B7.1 (CD80), B7.2 (CD86) on T
lymphocyte activity]. Pol Merkuriusz Lek 2002;12(69):185-9.
662. Saari SM, Vidgren MT, Herrala J, Turjanmaa VM, Koskinen MO, Nieminen MM.
Possibilities of formoterol to enhance the peripheral lung deposition of the inhaled
liposome corticosteroids. Respir Med 2002;96(12):999-1005.
663. Salome CM, Reddel HK, Ware SI, et al. Effect of budesonide on the perception
of induced airway narrowing in subjects with asthma. Am J Respir Crit Care Med
2002;165(1):15-21.
664. Schweisfurth H, Malinen A, Koskela T, Toivanen P, Ranki-Pesonen M.
Comparison of two budesonide powder inhalers, Easyhaler and Turbuhaler, in steroidnaive asthmatic patients. Respir Med 2002;96(8):599-606.
665. Sengstock DM, Obeidat O, Pasnoori V, Mehra P, Sandberg KR, McCullough PA.
Asthma, beta-agonists, and development of congestive heart failure: results of the
ABCHF study. J Card Fail 2002;8(4):232-8.
666. Serra-Batlles J, Plaza V, Badiola C, Morejon E. Patient perception and
acceptability of multidose dry powder inhalers: a randomized crossover comparison of
Diskus/Accuhaler with Turbuhaler. J Aerosol Med 2002;15(1):59-64.
667. Sethi GR, Sharma S, Batra V, Sharma DR. Double-blind, placebo-controlled
study of the efficacy and tolerability of nimesulide administered orally in acute bronchial
asthma. Am J Ther 2002;9(4):281-7.
668. Shapira MY, Berkman N, Ben-David G, Avital A, Bardach E, Breuer R. Shortterm acupuncture therapy is of no benefit in patients with moderate persistent asthma.
Chest 2002;121(5):1396-400.
669. Sharek PJ, Mayer ML, Loewy L, et al. Agreement among measures of asthma
status: a prospective study of low-income children with moderate to severe asthma.
Pediatrics 2002;110(4):797-804.
670. Shikanai T, Silverman ES, Morse BW, Lilly CM, Inoue H, Drazen JM. Sequence
variants in the FcepsilonRI alpha chain gene. J Appl Physiol 2002;93(1):37-41.
671. Silverman RA, Osborn H, Runge J, et al. IV magnesium sulfate in the treatment
of acute severe asthma: a multicenter randomized controlled trial. Chest
2002;122(2):489-97.
672. Siwik JP, Nowak RM, Zoratti EM. The evaluation and management of acute,
severe asthma. Med Clin North Am 2002;86(5):1049-71.
673. Soto-Quiros ME, Silverman EK, Hanson LA, Weiss ST, Celedon JC. Maternal
history, sensitization to allergens, and current wheezing, rhinitis, and eczema among
children in Costa Rica. Pediatr Pulmonol 2002;33(4):237-43.
674. Sousa AR, Parikh A, Scadding G, Corrigan CJ, Lee TH. Leukotriene-receptor
expression on nasal mucosal inflammatory cells in aspirin-sensitive rhinosinusitis. N
Engl J Med 2002;347(19):1493-9.
675. Steinshamn S, Sandsund M, Sue-Chu M, Bjermer L. Effects of montelukast on
physical performance and exercise economy in adult asthmatics with exercise-induced
bronchoconstriction. Scand J Med Sci Sports 2002;12(4):211-7.
676. Stelmach I, Grzelewski T, Stelmach W, et al. [The effect of nedocromil sodium on
levels of IL-4 and IgE in serum of children with bronchial asthma]. Pol Merkuriusz Lek
2002;12(69):214-7.
677. Stelmach I, Grzelewski T, Stelmach W, et al. [Effect of triamcinolone acetonide,
montelukast, nedocromil sodium and formoterol on eosinophil blood counts, ECP serum
levels and clinical progression of asthma in children]. Pol Merkuriusz Lek
2002;12(69):208-13.
678. Stelmach I, Jerzynska J, Majak P, et al. [The effect of triamcinolone acetonide,
montelukast, nedocromil sodium, formoterol on levels levels of sICAM-1, sIL-2R in
serum and clinical course of asthma in children]. Pol Merkuriusz Lek 2002;12(68):99103.
679. Stelmach I, Jerzynska J, Bobrowska M, Brzozowska A, Majak P, Kuna P. [The
effect of inhaled heparin on post-leukotriene bronchoconstriction in children with
bronchial asthma]. Pol Merkuriusz Lek 2002;12(68):95-8.
680. Stelmach I, Jerzynska J, Kuna P. A randomized, double-blind trial of the effect of
glucocorticoid, antileukotriene and beta-agonist treatment on IL-10 serum levels in
children with asthma. Clin Exp Allergy 2002;32(2):264-9.
681. Stelmach I, Jerzynska J, Kuna P. A randomized, double-blind trial of the effect of
treatment with montelukast on bronchial hyperresponsiveness and serum eosinophilic
cationic protein (ECP), soluble interleukin 2 receptor (sIL-2R), IL-4, and soluble
intercellular adhesion molecule 1 (sICAM-1) in children with asthma. J Allergy Clin
Immunol 2002;109(2):257-63.
682. Stelmach I, Gorski P, Jerzynska J, Stelmach W, Majak P, Kuna P. A randomized,
double-blind trial of the effect of treatment with formoterol on clinical and inflammatory
parameters of asthma in children. Ann Allergy Asthma Immunol 2002;89(1):67-73.
683. Stergachis A, Gardner JS, Anderson MT, Sullivan SD. Improving pediatric
asthma outcomes in the community setting: does pharmaceutical care make a
difference? J Am Pharm Assoc (Wash) 2002;42(5):743-52.
684. Stevens CA, Wesseldine LJ, Couriel JM, Dyer AJ, Osman LM, Silverman M.
Parental education and guided self-management of asthma and wheezing in the preschool child: a randomised controlled trial. Thorax 2002;57(1):39-44.
685. Stevenson J, Cornah D, Evrard P, et al. Long-term evaluation of the impact of the
h1-receptor antagonist cetirizine on the behavioral, cognitive, and psychomotor
development of very young children with atopic dermatitis. Pediatr Res 2002;52(2):2517.
686. Stewart IB, Labreche JM, McKenzie DC. Acute formoterol administration has no
ergogenic effect in nonasthmatic athletes. Med Sci Sports Exerc 2002;34(2):213-7.
687. Strunk RC, Sternberg AL, Bacharier LB, Szefler SJ. Nocturnal awakening caused
by asthma in children with mild-to-moderate asthma in the childhood asthma
management program. J Allergy Clin Immunol 2002;110(3):395-403.
688. Strunk RC, Bender B, Young DA, et al. Predictors of protocol adherence in a
pediatric asthma clinical trial. J Allergy Clin Immunol 2002;110(4):596-602.
689. Sundblad BM, Palmberg L, Larsson K. Bronchial responsiveness to eucapnic
hyperventilation and methacholine following exposure to organic dust. Chest
2002;122(1):363-8.
690. Szefler SJ, Martin RJ, King TS, et al. Significant variability in response to inhaled
corticosteroids for persistent asthma. J Allergy Clin Immunol 2002;109(3):410-8.
691. Szefler SJ, Warner J, Staab D, et al. Switching from conventional to extrafine
aerosol beclomethasone dipropionate therapy in children: a 6-month, open- label,
randomized trial. J Allergy Clin Immunol 2002;110(1):45-50.
692. Tal A, Simon G, Vermeulen JH, et al. Budesonide/formoterol in a single inhaler
versus inhaled corticosteroids alone in the treatment of asthma. Pediatr Pulmonol
2002;34(5):342-50.
693. Terao I. [Effects of once-daily low-dose administration of sustained-release
theophylline on airway inflammation and airway hyperresponsiveness in patients with
asthma]. Arerugi 2002;51(4):364-70.
694. Thomas PS, Heywood G. Effects of inhaled tumour necrosis factor alpha in
subjects with mild asthma. Thorax 2002;57(9):774-8.
695. Tsai SL, Crain EF, Silver EJ, Goldman HS. What can we learn from chest
radiographs in hypoxemic asthmatics? Pediatr Radiol 2002;32(7):498-504.
696. Tsitoura S, Nestoridou K, Botis P, et al. Randomized trial to prevent sensitization
to mite allergens in toddlers and preschoolers by allergen reduction and education: oneyear results. Arch Pediatr Adolesc Med 2002;156(10):1021-7.
697. Tsoi AN, Apkhipov VV. [Pharmacodynamics of inhalation broncholytic agents
introduced in a single dose by nebulizer in patients with severe exacerbation of bronchial
asthma]. Ter Arkh 2002;74(3):17-21.
698. Tukiainen H, Rytila P, Hamalainen KM, Silvasti MS, Keski-Karhu J. Safety,
tolerability and acceptability of two dry powder inhalers in the administration of
budesonide in steroid-treated asthmatic patients. Respir Med 2002;96(4):221-9.
699. Ungar WJ, Chapman KR, Santos MT. Assessment of a medication-based
asthma index for population research. Am J Respir Crit Care Med 2002;165(2):190-4.
700. Van Rensen EL, Hiemstra PS, Rabe KF, Sterk PJ. Assessment of microvascular
leakage via sputum induction: the role of substance P and neurokinin A in patients with
asthma. Am J Respir Crit Care Med 2002;165(9):1275-9.
701. van Schayck CP, Cloosterman SG, Bijl-Hofland ID, van den Hoogen H, Folgering
HT, van Weel C. Is the increase in bronchial responsiveness or FEV1 shortly after
cessation of beta2-agonists reflecting a real deterioration of the disease in allergic
asthmatic patients? A comparison between short-acting and long-acting beta2-agonists.
Respir Med 2002;96(3):155-62.
702. van Schayck CP, Bijl-Hofland ID, Cloosterman SG, Folgering HT, van der
Elshout FJ, Van Weel C. Potential masking effect on dyspnoea perception by short- and
long-acting beta2-agonists in asthma. Eur Respir J 2002;19(2):240-5.
703. Verhoeven GT, Hegmans JP, Mulder PG, Bogaard JM, Hoogsteden HC, Prins
JB. Effects of fluticasone propionate in COPD patients with bronchial
hyperresponsiveness. Thorax 2002;57(8):694-700.
704. Visitsunthorn N, Moungnoi P, Saengsiriwut A, Wacharasindhu S. Linear growth
of prepubertal asthmatic Thai children receiving long-term inhaled corticosteroids. J Med
Assoc Thai 2002;85 Suppl 2:S599-606.
705. Vizi E, Huszar E, Csoma Z, et al. Plasma adenosine concentration increases
during exercise: a possible contributing factor in exercise-induced bronchoconstriction in
asthma. J Allergy Clin Immunol 2002;109(3):446-8.
706. Vollmer WM, Markson LE, O'Connor E, Frazier EA, Berger M, Buist AS.
Association of asthma control with health care utilization: a prospective evaluation. Am J
Respir Crit Care Med 2002;165(2):195-9.
707. Vondra V, Sladek K, Kotasova J, Terl M, Rossetti A, Cantini L. A new HFA-134a
propellant in the administration of inhaled BDP via the Jet spacer: controlled clinical trial
vs the conventional CFC. Respir Med 2002;96(10):784-9.
708. Wakefield M, Banham D, McCaul K, et al. Effect of feedback regarding urinary
cotinine and brief tailored advice on home smoking restrictions among low-income
parents of children with asthma: a controlled trial. Prev Med 2002;34(1):58-65.
709. Wallin A, Sandstrom T, Cioppa GD, Holgate S, Wilson S. The effects of regular
inhaled formoterol and budesonide on preformed Th-2 cytokines in mild asthmatics.
Respir Med 2002;96(12):1021-5.
710. Wang DY, Niti M, Smith JD, Yeoh KH, Ng TP. Rhinitis: do diagnostic criteria
affect the prevalence and treatment? Allergy 2002;57(2):150-4.
711. Ward C, Pais M, Bish R, et al. Airway inflammation, basement membrane
thickening and bronchial hyperresponsiveness in asthma. Thorax 2002;57(4):309-16.
712. Weinberger M, Murray MD, Marrero DG, et al. Effectiveness of pharmacist care
for patients with reactive airways disease: a randomized controlled trial. JAMA
2002;288(13):1594-602.
713. Weiner P, Magadle R, Massarwa F, Beckerman M, Berar-Yanay N. Influence of
gender and inspiratory muscle training on the perception of dyspnea in patients with
asthma. Chest 2002;122(1):197-201.
714. Whitford H, Walters EH, Levvey B, et al. Addition of inhaled corticosteroids to
systemic immunosuppression after lung transplantation: a double-blind, placebocontrolled trial. Transplantation 2002;73(11):1793-9.
715. Woessner KM, Simon RA, Stevenson DD. The safety of celecoxib in patients
with aspirin-sensitive asthma. Arthritis Rheum 2002;46(8):2201-6.
716. Woodcock A, Acerbi D, Poli G. Modulite technology: pharmacodynamic and
pharmacokinetic implications. Respir Med 2002;96 Suppl D:S9-15.
717. Yasuda H, Yamaya M, Yanai M, Ohrui T, Sasaki H. Increased blood
carboxyhaemoglobin concentrations in inflammatory pulmonary diseases. Thorax
2002;57(9):779-83.
718. Yilmaz A, Akkaya E. Evaluation of long-term efficacy of an asthma education
programme in an out-patient clinic. Respir Med 2002;96(7):519-24.
719. Yoos HL, Kitzman H, McMullen A, Henderson C, Sidora K. Symptom monitoring
in childhood asthma: a randomized clinical trial comparing peak expiratory flow rate with
symptom monitoring. Ann Allergy Asthma Immunol 2002;88(3):283-91.
720. Yoshida M, Aizawa H, Inoue H, et al. Effect of suplatast tosilate on airway
hyperresponsiveness and inflammation in asthma patients. J Asthma 2002;39(6):545-52.
721. Yurdakul AS, Calisir HC, Tunctan B, Ogretensoy M. Comparison of second
controller medications in addition to inhaled corticosteroid in patients with moderate
asthma. Respir Med 2002;96(5):322-9.
722. Zanconato S, Scollo M, Zaramella C, Landi L, Zacchello F, Baraldi E. Exhaled
carbon monoxide levels after a course of oral prednisone in children with asthma
exacerbation. J Allergy Clin Immunol 2002;109(3):440-5.
723. Zhao W, Rouatbi S, Tabka Z, Guenard H. Inhaled sodium fluoride decreases
airway responsiveness to acetylcholine analogs in vivo. Respir Physiol Neurobiol
2002;131(3):245-53.